Disease Clusters?

Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.

← Back to all clusters

Cluster 1

266 diseases · 912 shared-gene connections
266 Diseases
2,192 Unique genes
0.173 Avg. similarity score
Nasal cavity and paranasal sinus carcinoma Most-connected disease (33 links)
Log in to save this analysis

Save This Analysis

Disease Searched: Mediastinal yolk sac tumor Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.
Mediastinal yolk sac tumor Nasal cavity and paranasal sinus carcinoma Thyroid gland undifferentiated (anaplastic) carcinoma Epidermal appendage tumor Mixed lobular and ductal breast carcinoma Conjunctival intraepithelial neoplasm

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Nasal cavity and paranasal sinus carcinoma 33 33 85
Thyroid gland undifferentiated (anaplastic) carcinoma 28 28 276
Epidermal appendage tumor 26 26 39
Mixed lobular and ductal breast carcinoma 26 26 205
Conjunctival intraepithelial neoplasm 25 25 102
Ovarian yolk sac tumor 25 25 21
Breast carcinoma by gene expression profile 24 24 351
Endometrium adenocarcinoma 24 24 109
Lobular carcinoma 24 24 321
Pancreatic neuroendocrine tumor 22 22 204
Endometrial undifferentiated carcinoma 21 21 61
Leiomyosarcoma 21 21 180
Endometrial endometrioid adenocarcinoma 20 20 430
Breast phyllodes tumor 19 19 93
Ovarian clear cell adenocarcinoma 19 19 189
Sebaceous gland neoplasms 18 18 46
Ocular sebaceous carcinoma 17 17 59
Ovarian carcinosarcoma 17 17 37
Sebaceous adenoma 17 17 35
Bile duct papillary neoplasm 16 16 23
Medullary carcinoma 16 16 146
Anaplastic oligodendroglioma 15 15 318
Wolffian duct adenocarcinoma 15 15 48
Appendix adenocarcinoma 14 14 102
Bladder cancer 14 14 33
Carcinosarcoma 14 14 24
Peripheral t-cell lymphoma, not otherwise specified 14 14 159
Ovarian teratoma 13 13 51
Uterine carcinosarcoma 13 13 221
Uterine corpus adenosarcoma 13 13 122
Adrenal cortex carcinoma 12 12 277
Clear cell adenocarcinoma 12 12 30
Malignant conjunctival melanoma 12 12 40
Syndromic intellectual disability 12 12 53
Testicular sex cord-stromal neoplasm 12 12 21
Appendix goblet cell carcinoid 11 11 74
Bladder urachal adenocarcinoma 11 11 26
Gallbladder papillary neoplasm 11 11 12
Sinonasal undifferentiated carcinoma 11 11 61
Wolffian adnexal tumor 11 11 54
Anaplastic ependymoma 10 10 34
Borderline ovarian mucinous tumor 10 10 48
Carcinoma of pharynx 10 10 26
Combined hepatocellular carcinoma and cholangiocarcinoma 10 10 162
Immunoblastic lymphadenopathy 10 10 112
Ovarian neoplasms 10 10 227
Desmoplastic/nodular medulloblastoma 9 9 11
Differentiated thyroid carcinoma 9 9 188
Endometrial clear cell adenocarcinoma 9 9 136
Endometrial mixed adenocarcinoma 9 9 103
Ganglioglioma 9 9 22
Hairy cell leukemia 9 9 144
Head and neck cancer 9 9 168
Ileal neuroendocrine tumor g1 9 9 25
Pseudomyxoma peritonei 9 9 64
Aggressive nk-cell leukemia 8 8 77
Cerebellar pilocytic astrocytoma 8 8 29
Choriocarcinoma of testis 8 8 20
Colon adenoma 8 8 40
Extranodal nasal nk/t cell lymphoma 8 8 132
Follicular variant thyroid gland papillary carcinoma 8 8 45
Gastric adenosquamous carcinoma 8 8 26
Luminal b breast carcinoma 8 8 99
Lung adenocarcinoma in situ 8 8 37
Testicular seminoma 8 8 165
Thymoma 8 8 47
Thymoma type b3 8 8 25
Urinary bladder neoplasms 8 8 142
Adrenal gland pheochromocytoma 7 7 23
Adrenocorticotropic hormone-producing pituitary gland adenoma 7 7 42
Carcinoid tumor 7 7 157
Carcinoma in situ 7 7 84
Choroid plexus papilloma 7 7 32
Colorectal neuroendocrine tumor g1 7 7 14
Fibroadenoma 7 7 31
Langerhans cell histiocytosis 7 7 30
Luminal a breast carcinoma 7 7 84
Lung benign neoplasm 7 7 63
Lung sclerosing hemangioma 7 7 58
Mucoepidermoid carcinoma of parotid gland 7 7 78
Pleomorphic xanthoastrocytoma 7 7 22
Pleural biphasic mesothelioma 7 7 96
Primary cutaneous t-cell non-hodgkin lymphoma 7 7 13
Pulmonary blastoma 7 7 75
Rectum adenoma 7 7 19
Seminoma 7 7 54
Skin appendage carcinoma 7 7 25
Small intestine adenocarcinoma 7 7 145
Solid pseudopapillary neoplasm of the pancreas 7 7 29
Testicular sertoli cell tumor 7 7 21
Urethra clear cell adenocarcinoma 7 7 15
Vulvar intraepithelial neoplasia 7 7 47
Acinic cell breast carcinoma 6 6 34
Anaplastic large cell lymphoma 6 6 74
Anaplastic oligoastrocytoma 6 6 35
Benign thyroid gland neoplasm 6 6 41
Breast adenosis 6 6 17
Cholangiocarcinoma 6 6 38
Clear cell meningioma 6 6 32
Giant cell tumor of bone 6 6 15
Granulosa cell tumor of ovary 6 6 87
Hepatocellular adenoma 6 6 42
Keratocystic odontogenic tumor 6 6 12
Leiomyoma 6 6 56
Liver neoplasms 6 6 152
Lung adenoma 6 6 20
Lung inflammatory myofibroblastic tumor 6 6 60
Lung neoplasms 6 6 254
Major salivary gland carcinoma 6 6 50
Malignant epithelioid mesothelioma 6 6 34
Malignant ovarian mixed epithelial tumor 6 6 31
Malignant pancreatic neoplasm 6 6 28
Malignant syringoma 6 6 88
Melanocytic neoplasm 6 6 38
Myxofibrosarcoma 6 6 33
Nasopharyngeal carcinoma 6 6 23
Ovarian mucinous adenocarcinoma 6 6 137
Pancreatic neoplasms 6 6 117
Parathyroid gland adenoma 6 6 58
Pleural epithelioid mesothelioma 6 6 206
Rectum malignant melanoma 6 6 24
Renal cell carcinoma 6 6 315
Sertoli-leydig cell tumor of ovary 6 6 35
Sezary syndrome 6 6 27
Spitz nevus 6 6 62
Testicular teratoma 6 6 53
Testicular yolk sac tumor 6 6 28
Thyroid gland oncocytic adenoma 6 6 88
Urethra adenocarcinoma 6 6 17
Uveal melanoma 6 6 185
Adnexal spiradenoma/cylindroma of a sweat gland 5 5 31
Adrenal gland neuroblastoma 5 5 66
Benign adrenal gland pheochromocytoma 5 5 54
Benign neoplasm of pancreas 5 5 33
Capillary hemangioma 5 5 15
Carcinoma of liver and intrahepatic biliary tract 5 5 16
Cervical adenosquamous carcinoma 5 5 41
Craniopharyngioma 5 5 31
Cystic neoplasm 5 5 11
Endometrioid stromal sarcoma 5 5 53
Giant cell glioblastoma 5 5 13
Gliosarcoma 5 5 37
Hepatoblastoma 5 5 69
Kidney neoplasms 5 5 40
Kidney oncocytoma 5 5 37
Lung sarcomatoid carcinoma 5 5 58
Malignant germ cell tumor 5 5 37
Mediastinal malignant germ cell tumor 5 5 14
Melanocytic nevus 5 5 203
Mesothelioma 5 5 259
Mucoepidermoid carcinoma 5 5 37
Neoplasm of mature b-cells 5 5 191
Neuroblastoma 5 5 269
Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 5 5 1
Oligoastrocytoma 5 5 29
Ovarian endometrioid adenocarcinoma 5 5 83
Pancreatic insulinoma 5 5 27
Pancreatoblastoma 5 5 30
Parotid gland carcinoma ex pleomorphic adenoma 5 5 11
Poroma 5 5 17
Primary central chondrosarcoma 5 5 50
Prostate neuroendocrine neoplasm 5 5 34
Salivary duct carcinoma 5 5 190
Salivary gland neoplasms 5 5 75
Sarcoma 5 5 158
Skin angiosarcoma 5 5 126
Spinal cord astrocytoma 5 5 42
Spindle cell intraocular melanoma 5 5 54
Spindle cell melanoma 5 5 86
Spleen angiosarcoma 5 5 18
Testicular carcinoma 5 5 92
Testicular germ cell tumor 5 5 186
Thymic undifferentiated carcinoma 5 5 37
Thymoma type ab 5 5 15
Undifferentiated gallbladder carcinoma 5 5 35
Well-differentiated liposarcoma 5 5 54
Wilms tumor 5 5 35
Yolk sac tumor 5 5 19
Ameloblastoma 4 4 12
Benign monoclonal gammopathy 4 4 17
Benign spiradenoma 4 4 18
Blue nevus 4 4 16
Carcinoma of esophagus 4 4 14
Cervical clear cell adenocarcinoma 4 4 10
Chondrosarcoma 4 4 77
Colorectal adenoma 4 4 204
Colorectal neoplasms 4 4 291
Digestive system neoplasms 4 4 162
Endometrial neoplasms 4 4 132
Follicular dendritic cell sarcoma 4 4 15
Ganglioneuroblastoma 4 4 14
Hamartoma of lung 4 4 13
Hepatosplenic t-cell lymphoma 4 4 25
Hyperplasia 4 4 43
Invasive breast carcinoma 4 4 64
Mediastinal yolk sac tumor 4 4 20
Melanocytic skin neoplasm 4 4 33
Mesonephric adenocarcinoma 4 4 10
Moyamoya angiopathy 4 4 36
Non-functional pancreatic neuroendocrine tumor 4 4 85
Ovarian mixed germ cell neoplasm 4 4 15
Pulmonary alveolar microlithiasis 4 4 1
Rectal neoplasm 4 4 23
Schwannoma 4 4 74
Shukla-vernon syndrome 4 4 1
Small intestinal neuroendocrine tumor g1 4 4 135
Thrombocytopenia 6 4 4 1
Thyroid neoplasms 4 4 49
Undifferentiated pancreatic carcinoma with osteoclast-like giant cells 4 4 23
Uterine neoplasms 4 4 38
Bone osteosarcoma 3 3 30
Borderline ovarian serous tumor 3 3 13
Carcinogenesis 3 3 18
Chordoma 3 3 104
Cortisol-producing adrenal cortex adenoma 3 3 60
Extraoral halitosis due to methanethiol oxidase deficiency 3 3 1
Familial platelet disorder with associated myeloid malignancy 3 3 1
Hyperplastic polyp 3 3 25
Immunodeficiency 92 3 3 1
Intellectual developmental disorder, autosomal dominant 48 3 3 1
Joint contractures, osteochondromas, and b-cell lymphoma 3 3 1
Kinsship syndrome 3 3 1
Malignant adrenal gland pheochromocytoma 3 3 12
Mast cell leukemia 3 3 19
Metaplastic breast carcinoma 3 3 107
Mixed germ cell tumor 3 3 14
Nasal cavity and paranasal sinus squamous cell carcinoma 3 3 50
Non-functioning adrenal cortex adenoma 3 3 11
Normal breast-like subtype of breast carcinoma 3 3 19
Oculomotor-abducens synkinesis 3 3 1
Polydactyly-macrocephaly syndrome 3 3 1
Primary peritoneal carcinoma 3 3 79
Sifrim-hitz-weiss syndrome 3 3 1
Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 3 3 1
Atypical teratoid rhabdoid tumor 2 2 22
Autoinflammatory disease, systemic, with vasculitis 2 2 1
Cervicitis 2 2 1
Cortical thymoma 2 2 13
Diaphragm disease 2 2 2
Hyperchlorhidrosis, isolated 2 2 1
Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly 2 2 1
Mountain sickness 2 2 2
Orbit embryonal rhabdomyosarcoma 2 2 22
Papillary hidradenoma 2 2 17
Parotid gland acinic cell carcinoma 2 2 11
Pituitary adenoma 2 2 26
Pulmonary agenesis 2 2 1
Abdominal obesity-metabolic syndrome 3 1 1 1
Autosomal recessive osteopetrosis 8 1 1 1
Borderline personality disorder 1 1 1
Colobomatous macrophthalmia microcornea syndrome 1 1 1
Diets-jongmans syndrome 1 1 1
Fibromatosis, gingival, 5 1 1 1
Gabriele-de vries syndrome 1 1 1
Immunodeficiency 109 with lymphoproliferation 1 1 1
Immunodeficiency 96 1 1 1
Intellectual developmental disorder dysmorphic ocular 1 1 1
Lymphangiosarcoma 1 1 17
Mental retardation, autosomal recessive 67 1 1 1
Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 1 1 1
Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 1 1 1
Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 1 1 1
Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language 1 1 1
Neurodevelopmental, jaw, eye, and digital syndrome 1 1 1
Retinitis pigmentosa, hearing loss, premature aging, short stature, facial dysmorphism syndrome 1 1 1
Skeletal defects, genital hypoplasia, and impaired intellectual development 1 1 1

Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)

Gene ⇵ Member diseases ⇵ Linked diseases
TP53 177 / 266 Acinic cell breast carcinoma, Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenal gland pheochromocytoma and 173 more
KRAS 123 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Ameloblastoma and 119 more
PIK3CA 114 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Adrenocorticotropic hormone-producing pituitary gland adenoma and 110 more
BRAF 112 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Ameloblastoma and 108 more
CDKN2A 106 / 266 Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Anaplastic ependymoma, Anaplastic large cell lymphoma and 102 more
NF1 103 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Aggressive nk-cell leukemia and 99 more
KMT2D 102 / 266 Acinic cell breast carcinoma, Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenal gland pheochromocytoma and 98 more
CTNNB1 101 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Ameloblastoma and 97 more
APC 99 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Ameloblastoma, Anaplastic oligodendroglioma and 95 more
ATM 96 / 266 Adrenal cortex carcinoma, Anaplastic large cell lymphoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma and 92 more
ARID1A 95 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma and 91 more
PTEN 92 / 266 Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma and 88 more
EGFR 91 / 266 Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 87 more
KMT2C 91 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Adrenocorticotropic hormone-producing pituitary gland adenoma and 87 more
CREBBP 84 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Anaplastic large cell lymphoma and 80 more
BRCA2 82 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligoastrocytoma and 78 more
NRAS 82 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Ameloblastoma and 78 more
ALK 81 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic ependymoma, Anaplastic large cell lymphoma and 77 more
FBXW7 77 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic ependymoma, Anaplastic oligodendroglioma and 73 more
NOTCH1 75 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic ependymoma and 71 more
EP300 73 / 266 Adrenal cortex carcinoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid and 69 more
ERBB4 73 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Anaplastic ependymoma and 69 more
SMARCA4 73 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Anaplastic oligoastrocytoma and 69 more
TSC2 70 / 266 Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 66 more
GNAS 69 / 266 Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Anaplastic oligodendroglioma and 65 more
RB1 69 / 266 Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma and 65 more
RET 69 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Anaplastic ependymoma and 65 more
ERBB2 68 / 266 Adrenal gland neuroblastoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 64 more
ATRX 67 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Adrenocorticotropic hormone-producing pituitary gland adenoma and 63 more
SMAD4 67 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 63 more
ARID2 66 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 62 more
BCOR 66 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Adrenocorticotropic hormone-producing pituitary gland adenoma and 62 more
KIT 66 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid, Breast carcinoma by gene expression profile and 62 more
NOTCH2 66 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic large cell lymphoma and 62 more
KMT2A 64 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid and 60 more
FAT1 63 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Aggressive nk-cell leukemia and 59 more
LRP1B 63 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Aggressive nk-cell leukemia and 59 more
MTOR 63 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 59 more
BRCA1 62 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic oligodendroglioma and 58 more
KDR 62 / 266 Adrenal cortex carcinoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Anaplastic ependymoma, Anaplastic oligodendroglioma and 58 more
MET 62 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic oligodendroglioma and 58 more
PTCH1 62 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma and 58 more
SETD2 62 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia and 58 more
HRAS 60 / 266 Adrenal gland pheochromocytoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Ameloblastoma, Benign adrenal gland pheochromocytoma and 56 more
MED12 60 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid and 56 more
AKT1 58 / 266 Adrenal cortex carcinoma, Appendix adenocarcinoma, Benign spiradenoma, Benign thyroid gland neoplasm and 54 more
ARID1B 58 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal gland neuroblastoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma and 54 more
DICER1 58 / 266 Adrenocorticotropic hormone-producing pituitary gland adenoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 54 more
ZFHX3 58 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma and 54 more
FGFR2 57 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Ameloblastoma, Anaplastic oligodendroglioma and 53 more
POLE 57 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma, Benign adrenal gland pheochromocytoma and 53 more
TET2 56 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma and 52 more
DNMT3A 55 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic large cell lymphoma and 51 more
ERBB3 55 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic oligodendroglioma and 51 more
FGFR3 55 / 266 Adrenal cortex carcinoma, Anaplastic ependymoma, Bladder cancer, Breast carcinoma by gene expression profile and 51 more
CDH1 54 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 50 more
KDM6A 53 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 49 more
FBXO11 52 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid and 48 more
MUC16 52 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Anaplastic oligoastrocytoma and 48 more
MSH6 51 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid and 47 more
PIK3R1 51 / 266 Adrenal cortex carcinoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma and 47 more
PTPRD 51 / 266 Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma and 47 more
BAP1 50 / 266 Adrenal cortex carcinoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Appendix adenocarcinoma, Bile duct papillary neoplasm and 46 more
ROS1 50 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Benign thyroid gland neoplasm and 46 more
CARD11 49 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 45 more
TSC1 49 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Bladder cancer and 45 more
ABL1 48 / 266 Adrenal cortex carcinoma, Appendix adenocarcinoma, Appendix goblet cell carcinoid, Breast carcinoma by gene expression profile and 44 more
FLT4 48 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic oligodendroglioma, Appendix goblet cell carcinoid and 44 more
MLH1 48 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 44 more
SMARCB1 48 / 266 Adrenal cortex carcinoma, Ameloblastoma, Anaplastic ependymoma, Anaplastic oligodendroglioma and 44 more
TERT 48 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma, Breast carcinoma by gene expression profile and 44 more
AR 47 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 43 more
MSH2 47 / 266 Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic ependymoma and 43 more
PDGFRA 47 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Ameloblastoma, Anaplastic oligoastrocytoma and 43 more
STK11 47 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Bile duct papillary neoplasm and 43 more
ASXL1 46 / 266 Adrenal cortex carcinoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma, Borderline ovarian mucinous tumor and 42 more
ATR 46 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Breast carcinoma by gene expression profile, Breast phyllodes tumor and 42 more
EPHA3 46 / 266 Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 42 more
IDH1 46 / 266 Aggressive nk-cell leukemia, Anaplastic ependymoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 42 more
SPEN 46 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Aggressive nk-cell leukemia, Anaplastic large cell lymphoma and 42 more
CHEK2 45 / 266 Adrenal cortex carcinoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 41 more
NSD1 45 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Benign thyroid gland neoplasm, Breast carcinoma by gene expression profile and 41 more
CSMD3 44 / 266 Anaplastic large cell lymphoma, Anaplastic oligoastrocytoma, Borderline ovarian mucinous tumor, Breast carcinoma by gene expression profile and 40 more
ESR1 44 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligoastrocytoma, Appendix goblet cell carcinoid and 40 more
IDH2 44 / 266 Adrenal cortex carcinoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma, Bladder cancer and 40 more
JAK3 44 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Breast carcinoma by gene expression profile and 40 more
SMO 44 / 266 Adrenal cortex carcinoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Ameloblastoma, Anaplastic oligodendroglioma and 40 more
GRIN2A 43 / 266 Acinic cell breast carcinoma, Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma and 39 more
NCOR1 43 / 266 Adrenal gland neuroblastoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 39 more
SF3B1 43 / 266 Adrenal gland neuroblastoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma, Blue nevus and 39 more
FLT3 42 / 266 Adrenal cortex carcinoma, Anaplastic ependymoma, Anaplastic large cell lymphoma, Benign adrenal gland pheochromocytoma and 38 more
PBRM1 42 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Anaplastic ependymoma, Anaplastic large cell lymphoma and 38 more
PTPRT 42 / 266 Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Aggressive nk-cell leukemia, Anaplastic oligodendroglioma and 38 more
STAG2 42 / 266 Adrenal gland pheochromocytoma, Adrenocorticotropic hormone-producing pituitary gland adenoma, Anaplastic oligodendroglioma, Bladder cancer and 38 more
VHL 42 / 266 Adrenal cortex carcinoma, Adrenal gland pheochromocytoma, Anaplastic oligodendroglioma, Benign adrenal gland pheochromocytoma and 38 more
BRD4 41 / 266 Anaplastic oligodendroglioma, Breast carcinoma by gene expression profile, Carcinoid tumor, Cervical adenosquamous carcinoma and 37 more
JAK1 41 / 266 Adrenal cortex carcinoma, Anaplastic large cell lymphoma, Anaplastic oligodendroglioma, Breast carcinoma by gene expression profile and 37 more
NTRK3 41 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Breast carcinoma by gene expression profile and 37 more
FGFR1 40 / 266 Adrenal gland neuroblastoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Appendix goblet cell carcinoid and 36 more
KDM5C 40 / 266 Adrenal cortex carcinoma, Anaplastic oligodendroglioma, Appendix adenocarcinoma, Breast carcinoma by gene expression profile and 36 more
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Pathways in cancer
BRAF, SMO, FGFR3, HRAS, KRAS, RB1, TP53, ABL1, AKT1, CDKN2A, EPAS1, ERBB2
 KEGG 262 / 533 2.7× 2.03e-62 6.50e-58 ✓ sig.
Transcriptional misregulation in cancer
TP53, MET, HPGD, FLT1, IL6, MITF, PRCC, RELA, TFE3, NR4A3, TAF15, ATF1
 KEGG 108 / 198 3.0× 6.28e-31 2.01e-27 ✓ sig.
Prostate cancer
BRAF, HRAS, KRAS, RB1, TP53, AKT1, ERBB2, GSTP1, MTOR, PIK3CA, PTEN, RELA
 KEGG 70 / 98 3.9× 9.18e-31 2.86e-27 ✓ sig.
Colorectal cancer
BRAF, HRAS, KRAS, TP53, AKT1, BIRC5, MTOR, PIK3CA, EGFR, SMAD4, BCL2, APC
 KEGG 63 / 87 4.0× 2.32e-28 6.17e-25 ✓ sig.
EGFR tyrosine kinase inhibitor resistance
BRAF, FGFR3, HRAS, KRAS, AKT1, ERBB2, MET, IL6, IL6R, MTOR, PIK3CA, PTEN
 KEGG 58 / 80 4.0× 2.97e-26 5.85e-23 ✓ sig.
PI3K-Akt signaling pathway
FGFR3, HRAS, KRAS, TP53, AKT1, ERBB2, MET, RET, FLT1, IFNA2, IL4R, IL6
 KEGG 148 / 361 2.2× 1.25e-24 1.93e-21 ✓ sig.
Proteoglycans in cancer
BRAF, SMO, HRAS, KRAS, TP53, AKT1, CAV1, ERBB2, MET, PPP1R12B, MTOR, PAK1
 KEGG 101 / 204 2.7× 1.38e-24 2.09e-21 ✓ sig.
Endometrial cancer
BRAF, HRAS, KRAS, TP53, AKT1, ERBB2, CDH1, PIK3CA, PTEN, EGFR, APC, AXIN1
 KEGG 47 / 59 4.4× 1.40e-24 2.11e-21 ✓ sig.
Non-small cell lung cancer
BRAF, HRAS, KRAS, RB1, TP53, AKT1, CDKN2A, ERBB2, MET, STAT5A, RET, ALK
 KEGG 53 / 73 4.0× 3.80e-24 5.46e-21 ✓ sig.
Chronic myeloid leukemia
BRAF, HRAS, KRAS, RB1, TP53, ABL1, AKT1, CDKN2A, STAT5A, PIK3CA, RELA, SMAD4
 KEGG 54 / 77 3.8× 2.16e-23 2.87e-20 ✓ sig.
Hepatocellular carcinoma
BRAF, SMARCB1, HRAS, KRAS, RB1, TP53, AKT1, CDKN2A, MET, NFE2L2, GSTM1, GSTP1
 KEGG 88 / 170 2.8× 2.72e-23 3.55e-20 ✓ sig.
Human T-cell leukemia virus 1 infection
HRAS, KRAS, RB1, CHEK2, TP53, AKT1, CDKN2A, STAT5A, IL6, PIK3CA, PTEN, RELA
 KEGG 104 / 224 2.5× 1.65e-22 1.96e-19 ✓ sig.
Hepatitis B
BRAF, HRAS, KRAS, RB1, TP53, AKT1, STAT5A, APAF1, BIRC5, IFNA2, IL6, PIK3CA
 KEGG 82 / 163 2.8× 9.36e-21 7.93e-18 ✓ sig.
Renal cell carcinoma
BRAF, HRAS, KRAS, AKT1, EPAS1, MET, ELOC, FLCN, PAK1, PIK3CA, PRCC, SLC2A1
 KEGG 48 / 70 3.8× 2.80e-20 2.16e-17 ✓ sig.
Melanoma
BRAF, HRAS, KRAS, RB1, TP53, AKT1, CDKN2A, MET, CDH1, MITF, PIK3CA, PTEN
 KEGG 49 / 73 3.7× 4.71e-20 3.50e-17 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
positive regulation of transcription by RNA polymerase II
SMO, SMARCB1, LPIN1, HRAS, RB1, TP53, ABL1, AKT1, CDKN2A, EPAS1, GATA3, MET
 GO:0045944 387 / 1,208 2.7× 2.59e-85 2.47e-80 ✓ sig.
positive regulation of DNA-templated transcription
SMO, CHEK2, TP53, CDKN2A, GATA3, NFE2L2, AGTR2, CDH1, RET, HNF1A, HNF1B, IL6
 GO:0045893 254 / 778 2.8× 1.24e-56 4.28e-52 ✓ sig.
positive regulation of gene expression
BRAF, SMO, HRAS, KRAS, TP53, AKT1, CAV1, CDKN2A, ERBB2, GATA3, NFE2L2, RET
 GO:0010628 177 / 504 3.0× 3.12e-44 4.57e-40 ✓ sig.
negative regulation of transcription by RNA polymerase II
SMO, RB1, TP53, CAV1, CDKN2A, CUX1, GATA3, POU5F1, ANXA4, FLCN, GSTP1, HNF1B
 GO:0000122 268 / 1,002 2.3× 2.63e-41 3.13e-37 ✓ sig.
positive regulation of cell population proliferation
SMO, LYN, FGFR3, HRAS, STAT5A, BIRC5, FLT1, IL6, IL6R, MTOR, PAK1, PRAME
 GO:0008284 171 / 532 2.7× 5.07e-37 4.95e-33 ✓ sig.
negative regulation of apoptotic process
BRAF, SMO, TP53, AKR1A1, AKT1, ERBB2, PTGS2, ANXA4, BIRC5, BIRC7, CASP2, CAT
 GO:0043066 167 / 524 2.7× 1.20e-35 9.72e-32 ✓ sig.
negative regulation of cell population proliferation
SMARCB1, LYN, HRAS, RB1, TP53, CAV1, CDKN2A, GATA3, BAP1, BCHE, BTG3, FLCN
 GO:0008285 145 / 444 2.8× 2.54e-32 1.76e-28 ✓ sig.
apoptotic process
SMO, FGFR3, RB1, CHEK2, TP53, ABL1, AKT1, CDKN2A, TP53BP2, APAF1, BIRC5, BIRC7
 GO:0006915 194 / 747 2.2× 4.75e-28 2.23e-24 ✓ sig.
regulation of cell cycle
HRAS, RB1, TP53, ABL1, CDKN2A, BAP1, BIRC7, NF2, PRCC, PTEN, TSC1, BRCA1
 GO:0051726 98 / 262 3.2× 2.66e-27 1.11e-23 ✓ sig.
response to xenobiotic stimulus
LYN, TP53, ABL1, GATA3, NFE2L2, CDH1, ADIPOQ, ALAD, BCHE, CAT, EEF2, GPX1
 GO:0009410 93 / 248 3.2× 4.58e-26 1.66e-22 ✓ sig.
regulation of DNA-templated transcription
RB1, CHEK2, TP53, ABL1, CUX1, EPAS1, GATA3, NFE2L2, POU5F1, STAT5A, KDM5C, KEAP1
 GO:0006355 305 / 1,454 1.8× 4.89e-26 1.76e-22 ✓ sig.
cell population proliferation
SMO, FGFR3, KRAS, RB1, TP53, AKT1, CAV1, ERBB2, GATA3, STAT5A, BAP1, TSC1
 GO:0008283 95 / 263 3.1× 3.53e-25 1.13e-21 ✓ sig.
DNA damage response
LYN, CHEK2, TP53, ABL1, CASP2, CRADD, FMN2, MTOR, OGG1, PAK1, PIDD1, SETD2
 GO:0006974 156 / 577 2.3× 1.25e-24 3.70e-21 ✓ sig.
regulation of cell population proliferation
BRAF, HRAS, TP53, ABL1, ERBB2, PTGS2, STAT5A, ALK, BIRC7, FLT1, MITF, NF2
 GO:0042127 80 / 201 3.4× 1.45e-24 4.20e-21 ✓ sig.
cell migration
AKT1, PAFAH1B1, CDH1, FLT1, FMN2, L1CAM, PAK1, PIK3CA, PTEN, BCL2, PDGFRA, KIT
 GO:0016477 102 / 303 2.9× 3.51e-24 9.61e-21 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Breast carcinoma by gene expression profile Lobular carcinoma 0.599 249 < 1e-300 < 1e-300 ✓ sig.
Breast carcinoma by gene expression profile Endometrial endometrioid adenocarcinoma 0.580 284 < 1e-300 < 1e-300 ✓ sig.
Endometrial endometrioid adenocarcinoma Lobular carcinoma 0.563 268 < 1e-300 < 1e-300 ✓ sig.
Anaplastic oligodendroglioma Breast carcinoma by gene expression profile 0.505 222 < 1e-300 < 1e-300 ✓ sig.
Anaplastic oligodendroglioma Endometrial endometrioid adenocarcinoma 0.497 246 < 1e-300 < 1e-300 ✓ sig.
Breast carcinoma by gene expression profile Thyroid gland undifferentiated (anaplastic) carcinoma 0.501 207 1.14e-312 1.08e-310 ✓ sig.
Endometrial endometrioid adenocarcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.444 215 2.27e-305 2.12e-303 ✓ sig.
Anaplastic oligodendroglioma Lobular carcinoma 0.484 206 1.34e-300 1.23e-298 ✓ sig.
Adrenal cortex carcinoma Endometrial endometrioid adenocarcinoma 0.429 210 9.29e-293 8.46e-291 ✓ sig.
Breast carcinoma by gene expression profile Mixed lobular and ductal breast carcinoma 0.472 176 9.03e-283 8.15e-281 ✓ sig.
Lobular carcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.468 188 2.11e-277 1.87e-275 ✓ sig.
Endometrial endometrioid adenocarcinoma Mixed lobular and ductal breast carcinoma 0.405 181 3.01e-275 2.65e-273 ✓ sig.
Endometrial endometrioid adenocarcinoma Pancreatic neuroendocrine tumor 0.400 179 8.80e-271 7.68e-269 ✓ sig.
Adrenal cortex carcinoma Breast carcinoma by gene expression profile 0.434 188 4.29e-266 3.69e-264 ✓ sig.
Anaplastic oligodendroglioma Thyroid gland undifferentiated (anaplastic) carcinoma 0.439 179 3.53e-257 2.98e-255 ✓ sig.
Breast carcinoma by gene expression profile Pancreatic neuroendocrine tumor 0.431 165 4.38e-254 3.68e-252 ✓ sig.
Lobular carcinoma Mixed lobular and ductal breast carcinoma 0.450 161 8.82e-252 7.36e-250 ✓ sig.
Adrenal cortex carcinoma Anaplastic oligodendroglioma 0.413 172 1.08e-240 8.53e-239 ✓ sig.
Lobular carcinoma Pancreatic neuroendocrine tumor 0.431 156 1.08e-239 8.38e-238 ✓ sig.
Endometrial endometrioid adenocarcinoma Uterine carcinosarcoma 0.364 172 1.13e-239 8.78e-238 ✓ sig.
Endometrial endometrioid adenocarcinoma Pleural epithelioid mesothelioma 0.344 161 5.19e-224 3.86e-222 ✓ sig.
Anaplastic oligodendroglioma Pancreatic neuroendocrine tumor 0.403 148 7.68e-221 5.63e-219 ✓ sig.
Leiomyosarcoma Lobular carcinoma 0.395 140 2.29e-215 1.66e-213 ✓ sig.
Breast carcinoma by gene expression profile Leiomyosarcoma 0.365 140 2.88e-208 2.03e-206 ✓ sig.
Breast carcinoma by gene expression profile Uterine carcinosarcoma 0.361 150 8.36e-208 5.89e-206 ✓ sig.
Endometrial endometrioid adenocarcinoma Salivary duct carcinoma 0.318 148 6.59e-204 4.58e-202 ✓ sig.
Endometrial endometrioid adenocarcinoma Melanocytic nevus 0.314 150 2.93e-200 2.02e-198 ✓ sig.
Endometrial endometrioid adenocarcinoma Neoplasm of mature b-cells 0.312 146 2.53e-199 1.73e-197 ✓ sig.
Lobular carcinoma Uterine carcinosarcoma 0.361 142 1.61e-197 1.10e-195 ✓ sig.
Breast carcinoma by gene expression profile Renal cell carcinoma 0.318 159 4.03e-190 2.72e-188 ✓ sig.
Thyroid gland undifferentiated (anaplastic) carcinoma Uterine carcinosarcoma 0.373 133 1.00e-189 6.75e-188 ✓ sig.
Breast carcinoma by gene expression profile Melanocytic nevus 0.327 135 3.58e-183 2.35e-181 ✓ sig.
Breast carcinoma by gene expression profile Differentiated thyroid carcinoma 0.327 131 1.90e-182 1.24e-180 ✓ sig.
Breast carcinoma by gene expression profile Peripheral t-cell lymphoma, not otherwise specified 0.324 123 3.39e-181 2.21e-179 ✓ sig.
Ovarian clear cell adenocarcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.367 123 5.30e-181 3.44e-179 ✓ sig.
Leiomyosarcoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.369 121 1.05e-180 6.80e-179 ✓ sig.
Breast carcinoma by gene expression profile Head and neck cancer 0.322 125 1.51e-179 9.77e-178 ✓ sig.
Breast carcinoma by gene expression profile Neoplasm of mature b-cells 0.321 130 1.12e-178 7.21e-177 ✓ sig.
Adrenal cortex carcinoma Ovarian clear cell adenocarcinoma 0.362 122 1.88e-178 1.21e-176 ✓ sig.
Mixed lobular and ductal breast carcinoma Pancreatic neuroendocrine tumor 0.401 115 8.43e-178 5.38e-176 ✓ sig.
Differentiated thyroid carcinoma Lobular carcinoma 0.335 126 1.31e-177 8.35e-176 ✓ sig.
Endometrial endometrioid adenocarcinoma Renal cell carcinoma 0.281 162 1.57e-177 9.98e-176 ✓ sig.
Endometrial endometrioid adenocarcinoma Testicular seminoma 0.278 128 1.93e-175 1.21e-173 ✓ sig.
Lobular carcinoma Melanocytic nevus 0.325 127 1.99e-172 1.23e-170 ✓ sig.
Differentiated thyroid carcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.352 119 2.41e-172 1.48e-170 ✓ sig.
Head and neck cancer Lobular carcinoma 0.327 119 1.25e-171 7.66e-170 ✓ sig.
Digestive system neoplasms Endometrial endometrioid adenocarcinoma 0.273 126 1.47e-171 9.04e-170 ✓ sig.
Adrenal cortex carcinoma Pleural epithelioid mesothelioma 0.345 122 3.42e-171 2.10e-169 ✓ sig.
Lobular carcinoma Medullary carcinoma 0.322 112 6.50e-169 3.96e-167 ✓ sig.
Lobular carcinoma Peripheral t-cell lymphoma, not otherwise specified 0.321 115 5.22e-168 3.17e-166 ✓ sig.
Leiomyosarcoma Mixed lobular and ductal breast carcinoma 0.395 107 6.10e-168 3.70e-166 ✓ sig.
Leiomyosarcoma Pancreatic neuroendocrine tumor 0.386 105 1.70e-163 1.02e-161 ✓ sig.
Medullary carcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.343 106 2.43e-163 1.46e-161 ✓ sig.
Lobular carcinoma Salivary duct carcinoma 0.312 120 4.09e-163 2.44e-161 ✓ sig.
Renal cell carcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.298 134 8.59e-163 5.12e-161 ✓ sig.
Lobular carcinoma Renal cell carcinoma 0.284 139 3.36e-160 1.97e-158 ✓ sig.
Breast carcinoma by gene expression profile Sarcoma 0.290 113 1.45e-158 8.48e-157 ✓ sig.
Pleural epithelioid mesothelioma Thyroid gland undifferentiated (anaplastic) carcinoma 0.323 116 1.51e-158 8.77e-157 ✓ sig.
Lobular carcinoma Testicular seminoma 0.305 112 6.20e-158 3.60e-156 ✓ sig.
Mixed lobular and ductal breast carcinoma Ovarian clear cell adenocarcinoma 0.363 103 3.31e-155 1.91e-153 ✓ sig.
Melanocytic nevus Thyroid gland undifferentiated (anaplastic) carcinoma 0.318 114 4.66e-155 2.67e-153 ✓ sig.
Peripheral t-cell lymphoma, not otherwise specified Thyroid gland undifferentiated (anaplastic) carcinoma 0.325 105 4.43e-154 2.53e-152 ✓ sig.
Endometrial clear cell adenocarcinoma Lobular carcinoma 0.297 103 9.76e-154 5.56e-152 ✓ sig.
Salivary duct carcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.318 111 1.52e-153 8.66e-152 ✓ sig.
Lobular carcinoma Neoplasm of mature b-cells 0.292 114 1.60e-150 9.03e-149 ✓ sig.
Anaplastic oligodendroglioma Testicular seminoma 0.293 108 1.07e-149 6.00e-148 ✓ sig.
Breast carcinoma by gene expression profile Uveal melanoma 0.276 115 9.03e-149 5.05e-147 ✓ sig.
Breast carcinoma by gene expression profile Testicular seminoma 0.276 110 2.54e-148 1.42e-146 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.305 101 2.48e-143 1.36e-141 ✓ sig.
Endometrial clear cell adenocarcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.306 95 8.59e-143 4.68e-141 ✓ sig.
Medullary carcinoma Pancreatic neuroendocrine tumor 0.356 90 7.95e-142 4.31e-140 ✓ sig.
Sarcoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.302 99 3.97e-141 2.14e-139 ✓ sig.
Adrenal cortex carcinoma Endometrial clear cell adenocarcinoma 0.301 94 2.79e-140 1.49e-138 ✓ sig.
Anaplastic oligodendroglioma Combined hepatocellular carcinoma and cholangiocarcinoma 0.278 103 6.81e-140 3.64e-138 ✓ sig.
Anaplastic oligodendroglioma Carcinoid tumor 0.274 101 6.77e-138 3.59e-136 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Lobular carcinoma 0.272 102 2.79e-137 1.47e-135 ✓ sig.
Leiomyosarcoma Sarcoma 0.357 87 1.23e-136 6.49e-135 ✓ sig.
Pancreatic neuroendocrine tumor Peripheral t-cell lymphoma, not otherwise specified 0.328 88 4.26e-132 2.20e-130 ✓ sig.
Carcinoid tumor Lobular carcinoma 0.262 98 4.27e-131 2.20e-129 ✓ sig.
Endometrial endometrioid adenocarcinoma Small intestinal neuroendocrine tumor g1 0.216 99 3.18e-130 1.64e-128 ✓ sig.
Medullary carcinoma Mixed lobular and ductal breast carcinoma 0.328 85 6.43e-130 3.29e-128 ✓ sig.
Lobular carcinoma Uveal melanoma 0.259 103 6.42e-130 3.29e-128 ✓ sig.
Anaplastic oligodendroglioma Hairy cell leukemia 0.256 93 7.68e-127 3.89e-125 ✓ sig.
Anaplastic oligodendroglioma Uveal melanoma 0.254 101 1.60e-126 8.07e-125 ✓ sig.
Head and neck cancer Ovarian clear cell adenocarcinoma 0.320 85 6.33e-126 3.19e-124 ✓ sig.
Thyroid gland undifferentiated (anaplastic) carcinoma Uveal melanoma 0.267 96 4.12e-124 2.07e-122 ✓ sig.
Digestive system neoplasms Thyroid gland undifferentiated (anaplastic) carcinoma 0.270 92 7.35e-124 3.68e-122 ✓ sig.
Mixed lobular and ductal breast carcinoma Sarcoma 0.309 84 2.52e-123 1.26e-121 ✓ sig.
Endometrial endometrioid adenocarcinoma Ovarian mucinous adenocarcinoma 0.208 97 3.23e-123 1.62e-121 ✓ sig.
Differentiated thyroid carcinoma Leiomyosarcoma 0.308 85 6.19e-123 3.09e-121 ✓ sig.
Endometrial clear cell adenocarcinoma Mixed lobular and ductal breast carcinoma 0.315 80 1.96e-122 9.74e-121 ✓ sig.
Pancreatic neuroendocrine tumor Small intestine adenocarcinoma 0.310 81 1.77e-121 8.68e-120 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Uterine carcinosarcoma 0.291 85 2.92e-120 1.43e-118 ✓ sig.
Endometrium adenocarcinoma Pancreatic neuroendocrine tumor 0.318 74 3.51e-120 1.72e-118 ✓ sig.
Endometrium adenocarcinoma Mixed lobular and ductal breast carcinoma 0.316 74 5.54e-120 2.70e-118 ✓ sig.
Extranodal nasal nk/t cell lymphoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.264 84 1.82e-119 8.85e-118 ✓ sig.
Differentiated thyroid carcinoma Medullary carcinoma 0.313 78 4.33e-118 2.10e-116 ✓ sig.
Hairy cell leukemia Uterine carcinosarcoma 0.291 81 6.95e-118 3.36e-116 ✓ sig.
Endometrium adenocarcinoma Leiomyosarcoma 0.335 71 7.17e-118 3.47e-116 ✓ sig.
Adrenal cortex carcinoma Extranodal nasal nk/t cell lymphoma 0.259 83 3.82e-117 1.84e-115 ✓ sig.
Adrenal cortex carcinoma Hairy cell leukemia 0.258 85 2.13e-116 1.02e-114 ✓ sig.
Adrenal cortex carcinoma Uveal melanoma 0.252 92 3.97e-116 1.89e-114 ✓ sig.
Endometrial endometrioid adenocarcinoma Mesothelioma 0.204 116 8.66e-115 4.09e-113 ✓ sig.
Mixed lobular and ductal breast carcinoma Small intestine adenocarcinoma 0.294 78 1.23e-114 5.82e-113 ✓ sig.
Breast carcinoma by gene expression profile Testicular germ cell tumor 0.224 97 5.81e-114 2.73e-112 ✓ sig.
Uterine carcinosarcoma Uterine corpus adenosarcoma 0.287 75 1.15e-113 5.39e-112 ✓ sig.
Head and neck cancer Uterine corpus adenosarcoma 0.327 70 7.24e-113 3.37e-111 ✓ sig.
Pancreatic neuroendocrine tumor Uterine corpus adenosarcoma 0.297 73 2.54e-112 1.18e-110 ✓ sig.
Conjunctival intraepithelial neoplasm Mixed lobular and ductal breast carcinoma 0.297 69 2.04e-111 9.45e-110 ✓ sig.
Conjunctival intraepithelial neoplasm Leiomyosarcoma 0.321 67 2.29e-111 1.06e-109 ✓ sig.
Lobular carcinoma Testicular germ cell tumor 0.228 93 6.26e-111 2.88e-109 ✓ sig.
Head and neck cancer Sarcoma 0.301 74 3.40e-110 1.56e-108 ✓ sig.
Appendix adenocarcinoma Mixed lobular and ductal breast carcinoma 0.293 68 1.65e-109 7.51e-108 ✓ sig.
Leiomyosarcoma Small intestine adenocarcinoma 0.298 73 3.49e-109 1.58e-107 ✓ sig.
Breast carcinoma by gene expression profile Ovarian mucinous adenocarcinoma 0.213 85 3.49e-108 1.57e-106 ✓ sig.
Endometrial endometrioid adenocarcinoma Neuroblastoma 0.195 113 3.87e-108 1.74e-106 ✓ sig.
Testicular carcinoma Testicular germ cell tumor 0.306 64 1.19e-107 5.32e-106 ✓ sig.
Endometrial mixed adenocarcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.240 72 1.52e-107 6.78e-106 ✓ sig.
Digestive system neoplasms Ovarian clear cell adenocarcinoma 0.277 75 6.46e-106 2.86e-104 ✓ sig.
Carcinoid tumor Uterine carcinosarcoma 0.261 77 3.35e-105 1.47e-103 ✓ sig.
Extranodal nasal nk/t cell lymphoma Uterine carcinosarcoma 0.266 73 5.84e-105 2.55e-103 ✓ sig.
Testicular germ cell tumor Thyroid gland undifferentiated (anaplastic) carcinoma 0.232 86 6.00e-105 2.61e-103 ✓ sig.
Malignant syringoma Ovarian clear cell adenocarcinoma 0.297 62 1.84e-104 7.99e-103 ✓ sig.
Immunoblastic lymphadenopathy Peripheral t-cell lymphoma, not otherwise specified 0.318 64 2.04e-104 8.86e-103 ✓ sig.
Endometrium adenocarcinoma Medullary carcinoma 0.332 62 7.73e-104 3.33e-102 ✓ sig.
Leiomyosarcoma Uterine corpus adenosarcoma 0.294 67 1.71e-103 7.36e-102 ✓ sig.
Breast carcinoma by gene expression profile Mesothelioma 0.203 102 1.98e-103 8.51e-102 ✓ sig.
Appendix adenocarcinoma Pancreatic neuroendocrine tumor 0.278 65 1.48e-102 6.33e-101 ✓ sig.
Appendix adenocarcinoma Ovarian clear cell adenocarcinoma 0.285 63 1.78e-100 7.47e-99 ✓ sig.
Immunoblastic lymphadenopathy Pancreatic neuroendocrine tumor 0.270 66 3.98e-100 1.67e-98 ✓ sig.
Digestive system neoplasms Head and neck cancer 0.273 70 4.71e-100 1.97e-98 ✓ sig.
Carcinoid tumor Medullary carcinoma 0.286 66 9.44e-99 3.91e-97 ✓ sig.
Breast carcinoma by gene expression profile Ovarian neoplasms 0.197 94 5.69e-98 2.35e-96 ✓ sig.
Head and neck cancer Nasal cavity and paranasal sinus carcinoma 0.300 57 1.31e-97 5.41e-96 ✓ sig.
Medullary carcinoma Small intestine adenocarcinoma 0.291 64 1.32e-97 5.42e-96 ✓ sig.
Extranodal nasal nk/t cell lymphoma Pancreatic neuroendocrine tumor 0.260 68 2.32e-97 9.48e-96 ✓ sig.
Endometrial mixed adenocarcinoma Mixed lobular and ductal breast carcinoma 0.265 63 2.56e-97 1.05e-95 ✓ sig.
Breast carcinoma by gene expression profile Neuroblastoma 0.193 99 4.65e-97 1.90e-95 ✓ sig.
Endometrium adenocarcinoma Small intestine adenocarcinoma 0.312 59 6.87e-97 2.79e-95 ✓ sig.
Anaplastic oligodendroglioma Ovarian mucinous adenocarcinoma 0.206 77 1.45e-96 5.85e-95 ✓ sig.
Appendix adenocarcinoma Leiomyosarcoma 0.279 60 4.25e-95 1.70e-93 ✓ sig.
Breast phyllodes tumor Leiomyosarcoma 0.278 58 8.47e-94 3.35e-92 ✓ sig.
Anaplastic oligodendroglioma Mesothelioma 0.192 92 2.42e-92 9.42e-91 ✓ sig.
Ovarian mucinous adenocarcinoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.214 72 3.17e-92 1.23e-90 ✓ sig.
Immunoblastic lymphadenopathy Mixed lobular and ductal breast carcinoma 0.249 62 3.61e-91 1.39e-89 ✓ sig.
Mesothelioma Pancreatic neuroendocrine tumor 0.208 79 1.14e-90 4.37e-89 ✓ sig.
Carcinoid tumor Small intestine adenocarcinoma 0.265 62 1.97e-90 7.52e-89 ✓ sig.
Hairy cell leukemia Peripheral t-cell lymphoma, not otherwise specified 0.264 62 3.27e-90 1.24e-88 ✓ sig.
Adrenal cortex carcinoma Small intestinal neuroendocrine tumor g1 0.209 70 7.58e-90 2.87e-88 ✓ sig.
Endometrial clear cell adenocarcinoma Endometrium adenocarcinoma 0.299 55 1.36e-89 5.15e-88 ✓ sig.
Medullary carcinoma Nasal cavity and paranasal sinus carcinoma 0.302 52 1.79e-89 6.78e-88 ✓ sig.
Adrenal cortex carcinoma Mesothelioma 0.193 86 4.98e-89 1.87e-87 ✓ sig.
Mixed lobular and ductal breast carcinoma Neuroblastoma 0.201 78 1.61e-87 6.01e-86 ✓ sig.
Conjunctival intraepithelial neoplasm Endometrial clear cell adenocarcinoma 0.296 53 3.66e-87 1.37e-85 ✓ sig.
Ovarian neoplasms Thyroid gland undifferentiated (anaplastic) carcinoma 0.195 81 3.68e-87 1.37e-85 ✓ sig.
Immunoblastic lymphadenopathy Leiomyosarcoma 0.254 58 1.21e-86 4.48e-85 ✓ sig.
Melanocytic nevus Skin angiosarcoma 0.235 62 3.69e-86 1.36e-84 ✓ sig.
Pancreatic neuroendocrine tumor Testicular germ cell tumor 0.215 68 6.17e-84 2.26e-82 ✓ sig.
Luminal b breast carcinoma Mixed lobular and ductal breast carcinoma 0.232 56 2.47e-83 8.99e-82 ✓ sig.
Ovarian clear cell adenocarcinoma Ovarian neoplasms 0.206 70 2.76e-83 1.00e-81 ✓ sig.
Ovarian clear cell adenocarcinoma Skin angiosarcoma 0.234 59 1.75e-82 6.34e-81 ✓ sig.
Endometrium adenocarcinoma Nasal cavity and paranasal sinus carcinoma 0.324 46 2.39e-82 8.61e-81 ✓ sig.
Hairy cell leukemia Uterine corpus adenosarcoma 0.262 54 6.09e-82 2.18e-80 ✓ sig.
Appendix adenocarcinoma Endometrium adenocarcinoma 0.306 48 8.26e-82 2.96e-80 ✓ sig.
Breast phyllodes tumor Endometrium adenocarcinoma 0.313 47 8.43e-82 3.02e-80 ✓ sig.
Differentiated thyroid carcinoma Thyroid gland oncocytic adenoma 0.239 52 8.72e-81 3.09e-79 ✓ sig.
Appendix goblet cell carcinoid Head and neck cancer 0.254 48 2.49e-80 8.79e-79 ✓ sig.
Mixed lobular and ductal breast carcinoma Ovarian mucinous adenocarcinoma 0.216 60 4.37e-79 1.54e-77 ✓ sig.
Epidermal appendage tumor Sebaceous adenoma 0.718 28 4.52e-78 1.57e-76 ✓ sig.
Endometrial clear cell adenocarcinoma Endometrial mixed adenocarcinoma 0.268 49 5.80e-78 2.02e-76 ✓ sig.
Peripheral t-cell lymphoma, not otherwise specified Skin angiosarcoma 0.238 54 1.86e-77 6.45e-76 ✓ sig.
Breast phyllodes tumor Uterine corpus adenosarcoma 0.282 46 1.24e-76 4.28e-75 ✓ sig.
Chordoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.183 58 2.03e-76 7.03e-75 ✓ sig.
Breast phyllodes tumor Conjunctival intraepithelial neoplasm 0.301 44 2.95e-76 1.02e-74 ✓ sig.
Pleural biphasic mesothelioma Thyroid gland undifferentiated (anaplastic) carcinoma 0.181 56 3.54e-76 1.22e-74 ✓ sig.
Pancreatic neuroendocrine tumor Small intestinal neuroendocrine tumor g1 0.207 57 1.08e-74 3.67e-73 ✓ sig.
Non-functional pancreatic neuroendocrine tumor Thyroid gland undifferentiated (anaplastic) carcinoma 0.176 53 3.69e-74 1.25e-72 ✓ sig.
Conjunctival intraepithelial neoplasm Nasal cavity and paranasal sinus carcinoma 0.302 42 4.48e-74 1.52e-72 ✓ sig.
Endometrial mixed adenocarcinoma Peripheral t-cell lymphoma, not otherwise specified 0.238 49 7.95e-74 2.68e-72 ✓ sig.
Leiomyosarcoma Malignant syringoma 0.224 48 5.11e-73 1.72e-71 ✓ sig.
Ovarian clear cell adenocarcinoma Ovarian endometrioid adenocarcinoma 0.218 48 6.47e-73 2.17e-71 ✓ sig.
Extranodal nasal nk/t cell lymphoma Nasal cavity and paranasal sinus carcinoma 0.263 44 1.06e-72 3.56e-71 ✓ sig.
Anaplastic oligodendroglioma Luminal a breast carcinoma 0.157 54 1.38e-72 4.61e-71 ✓ sig.
Mixed lobular and ductal breast carcinoma Pulmonary blastoma 0.203 46 5.02e-71 1.66e-69 ✓ sig.
Luminal b breast carcinoma Medullary carcinoma 0.240 46 1.21e-70 3.99e-69 ✓ sig.
Carcinoma in situ Pancreatic neuroendocrine tumor 0.201 47 1.14e-69 3.75e-68 ✓ sig.
Pulmonary blastoma Uterine carcinosarcoma 0.189 46 2.59e-69 8.46e-68 ✓ sig.
Medullary carcinoma Thyroid gland oncocytic adenoma 0.239 44 3.26e-69 1.06e-67 ✓ sig.
Breast phyllodes tumor Nasal cavity and paranasal sinus carcinoma 0.293 39 6.91e-69 2.25e-67 ✓ sig.
Epidermal appendage tumor Sebaceous gland neoplasms 0.529 27 1.90e-67 6.12e-66 ✓ sig.
Appendix goblet cell carcinoid Conjunctival intraepithelial neoplasm 0.286 38 1.91e-67 6.14e-66 ✓ sig.
Granulosa cell tumor of ovary Mixed lobular and ductal breast carcinoma 0.195 47 2.02e-67 6.50e-66 ✓ sig.
Sebaceous adenoma Sebaceous gland neoplasms 0.542 26 1.33e-66 4.26e-65 ✓ sig.
Endometrial undifferentiated carcinoma Endometrium adenocarcinoma 0.279 36 7.35e-66 2.33e-64 ✓ sig.
Aggressive nk-cell leukemia Extranodal nasal nk/t cell lymphoma 0.244 40 9.03e-66 2.86e-64 ✓ sig.
Malignant syringoma Mixed lobular and ductal breast carcinoma 0.191 46 1.10e-65 3.48e-64 ✓ sig.
Ovarian endometrioid adenocarcinoma Uterine carcinosarcoma 0.181 46 5.35e-65 1.68e-63 ✓ sig.
Leiomyosarcoma Thyroid gland oncocytic adenoma 0.202 44 1.84e-64 5.78e-63 ✓ sig.
Metaplastic breast carcinoma Uterine carcinosarcoma 0.179 49 3.36e-64 1.05e-62 ✓ sig.
Endometrium adenocarcinoma Sebaceous gland neoplasms 0.274 32 4.18e-63 1.29e-61 ✓ sig.
Carcinoma in situ Peripheral t-cell lymphoma, not otherwise specified 0.210 41 2.55e-62 7.82e-61 ✓ sig.
Conjunctival intraepithelial neoplasm Endometrial undifferentiated carcinoma 0.274 34 4.73e-62 1.45e-60 ✓ sig.
Pancreatic neuroendocrine tumor Pleural biphasic mesothelioma 0.181 45 1.25e-61 3.81e-60 ✓ sig.
Luminal b breast carcinoma Nasal cavity and paranasal sinus carcinoma 0.255 36 1.24e-60 3.73e-59 ✓ sig.
Endometrial undifferentiated carcinoma Nasal cavity and paranasal sinus carcinoma 0.296 32 1.67e-60 5.04e-59 ✓ sig.
Appendix adenocarcinoma Appendix goblet cell carcinoid 0.259 35 2.12e-60 6.38e-59 ✓ sig.
Malignant syringoma Salivary duct carcinoma 0.182 42 4.40e-59 1.31e-57 ✓ sig.
Aggressive nk-cell leukemia Mixed lobular and ductal breast carcinoma 0.174 41 4.68e-59 1.39e-57 ✓ sig.
Appendix goblet cell carcinoid Endometrium adenocarcinoma 0.245 35 5.91e-59 1.75e-57 ✓ sig.
Chordoma Ovarian clear cell adenocarcinoma 0.180 44 9.21e-59 2.73e-57 ✓ sig.
Carcinoma in situ Ovarian clear cell adenocarcinoma 0.182 41 9.33e-59 2.76e-57 ✓ sig.
Endometrium adenocarcinoma Wolffian adnexal tumor 0.254 32 1.32e-58 3.91e-57 ✓ sig.
Breast phyllodes tumor Luminal b breast carcinoma 0.240 36 1.59e-58 4.69e-57 ✓ sig.
Mixed lobular and ductal breast carcinoma Ovarian endometrioid adenocarcinoma 0.174 42 1.65e-58 4.86e-57 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Sinonasal undifferentiated carcinoma 0.284 31 6.10e-58 1.79e-56 ✓ sig.
Breast carcinoma by gene expression profile Parathyroid gland adenoma 0.116 42 6.78e-58 1.99e-56 ✓ sig.
Head and neck cancer Pleural biphasic mesothelioma 0.189 41 9.88e-58 2.89e-56 ✓ sig.
Appendix adenocarcinoma Endometrial undifferentiated carcinoma 0.256 32 2.96e-57 8.58e-56 ✓ sig.
Endometrial mixed adenocarcinoma Endometrial undifferentiated carcinoma 0.254 32 4.36e-57 1.26e-55 ✓ sig.
Peripheral t-cell lymphoma, not otherwise specified Spindle cell melanoma 0.194 39 5.62e-57 1.62e-55 ✓ sig.
Adrenal gland neuroblastoma Pancreatic neuroendocrine tumor 0.168 38 7.65e-57 2.21e-55 ✓ sig.
Spindle cell intraocular melanoma Uveal melanoma 0.173 35 6.02e-56 1.73e-54 ✓ sig.
Ovarian clear cell adenocarcinoma Pleural biphasic mesothelioma 0.173 41 1.91e-55 5.44e-54 ✓ sig.
Metaplastic breast carcinoma Mixed lobular and ductal breast carcinoma 0.164 43 1.11e-54 3.16e-53 ✓ sig.
Luminal a breast carcinoma Mixed lobular and ductal breast carcinoma 0.164 40 1.49e-54 4.20e-53 ✓ sig.
Conjunctival intraepithelial neoplasm Luminal b breast carcinoma 0.219 35 1.61e-54 4.55e-53 ✓ sig.
Differentiated thyroid carcinoma Follicular variant thyroid gland papillary carcinoma 0.163 32 7.56e-54 2.12e-52 ✓ sig.
Medullary carcinoma Pulmonary blastoma 0.196 35 8.87e-54 2.48e-52 ✓ sig.
Aggressive nk-cell leukemia Peripheral t-cell lymphoma, not otherwise specified 0.186 36 1.65e-53 4.60e-52 ✓ sig.
Granulosa cell tumor of ovary Uterine corpus adenosarcoma 0.206 35 3.20e-53 8.89e-52 ✓ sig.
Adrenal gland neuroblastoma Leiomyosarcoma 0.171 35 1.19e-52 3.29e-51 ✓ sig.
Anaplastic large cell lymphoma Neoplasm of mature b-cells 0.165 37 1.52e-52 4.19e-51 ✓ sig.
Conjunctival intraepithelial neoplasm Granulosa cell tumor of ovary 0.216 33 4.99e-52 1.37e-50 ✓ sig.
Appendix goblet cell carcinoid Nasal cavity and paranasal sinus carcinoma 0.244 30 6.45e-52 1.77e-50 ✓ sig.
Spindle cell melanoma Uterine corpus adenosarcoma 0.201 34 1.44e-51 3.94e-50 ✓ sig.
Pleural epithelioid mesothelioma Pseudomyxoma peritonei 0.153 35 4.59e-51 1.25e-49 ✓ sig.
Colorectal adenoma Endometrial endometrioid adenocarcinoma 0.114 64 7.20e-51 1.95e-49 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Pleural biphasic mesothelioma 0.172 37 1.35e-50 3.66e-49 ✓ sig.
Conjunctival intraepithelial neoplasm Ocular sebaceous carcinoma 0.228 29 1.62e-50 4.38e-49 ✓ sig.
Conjunctival intraepithelial neoplasm Spindle cell melanoma 0.211 32 2.76e-50 7.44e-49 ✓ sig.
Luminal a breast carcinoma Ovarian clear cell adenocarcinoma 0.160 37 2.98e-50 8.02e-49 ✓ sig.
Breast phyllodes tumor Ovarian teratoma 0.243 27 5.13e-50 1.38e-48 ✓ sig.
Lung benign neoplasm Ovarian clear cell adenocarcinoma 0.158 34 9.90e-50 2.66e-48 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Ovarian teratoma 0.252 26 6.25e-49 1.66e-47 ✓ sig.
Endometrium adenocarcinoma Sinonasal undifferentiated carcinoma 0.213 29 6.55e-49 1.73e-47 ✓ sig.
Endometrium adenocarcinoma Granulosa cell tumor of ovary 0.199 32 9.23e-49 2.44e-47 ✓ sig.
Adrenal gland neuroblastoma Endometrial clear cell adenocarcinoma 0.188 31 1.18e-48 3.11e-47 ✓ sig.
Breast phyllodes tumor Carcinoma in situ 0.213 30 2.69e-48 7.07e-47 ✓ sig.
Endometrium adenocarcinoma Wolffian duct adenocarcinoma 0.214 27 3.68e-48 9.63e-47 ✓ sig.
Leiomyosarcoma Well-differentiated liposarcoma 0.157 31 5.18e-48 1.35e-46 ✓ sig.
Mucoepidermoid carcinoma of parotid gland Ovarian clear cell adenocarcinoma 0.154 35 6.21e-48 1.62e-46 ✓ sig.
Follicular variant thyroid gland papillary carcinoma Medullary carcinoma 0.177 28 7.08e-48 1.85e-46 ✓ sig.
Mucoepidermoid carcinoma of parotid gland Salivary duct carcinoma 0.153 35 9.36e-48 2.44e-46 ✓ sig.
Follicular variant thyroid gland papillary carcinoma Thyroid gland oncocytic adenoma 0.240 25 3.49e-47 9.04e-46 ✓ sig.
Anaplastic large cell lymphoma Hairy cell leukemia 0.175 32 4.33e-47 1.12e-45 ✓ sig.
Schwannoma Testicular seminoma 0.163 33 5.00e-47 1.29e-45 ✓ sig.
Primary peritoneal carcinoma Uterine carcinosarcoma 0.139 36 6.56e-47 1.69e-45 ✓ sig.
Chondrosarcoma Leiomyosarcoma 0.155 34 8.23e-47 2.12e-45 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Wolffian duct adenocarcinoma 0.243 25 9.54e-47 2.45e-45 ✓ sig.
Lung inflammatory myofibroblastic tumor Ovarian clear cell adenocarcinoma 0.150 32 1.40e-46 3.59e-45 ✓ sig.
Anaplastic large cell lymphoma Extranodal nasal nk/t cell lymphoma 0.180 31 2.09e-46 5.36e-45 ✓ sig.
Pseudomyxoma peritonei Testicular seminoma 0.161 31 2.84e-46 7.27e-45 ✓ sig.
Melanocytic neoplasm Spitz nevus 0.293 22 3.92e-46 1.00e-44 ✓ sig.
Immunoblastic lymphadenopathy Wolffian adnexal tumor 0.201 27 4.68e-46 1.19e-44 ✓ sig.
Colorectal adenoma Thyroid gland undifferentiated (anaplastic) carcinoma 0.121 51 3.47e-45 8.73e-44 ✓ sig.
Chordoma Conjunctival intraepithelial neoplasm 0.181 31 5.07e-45 1.27e-43 ✓ sig.
Carcinoid tumor Pseudomyxoma peritonei 0.161 30 7.70e-45 1.93e-43 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Spindle cell melanoma 0.203 28 8.45e-45 2.11e-43 ✓ sig.
Appendix adenocarcinoma Pulmonary blastoma 0.197 28 1.48e-44 3.69e-43 ✓ sig.
Conjunctival intraepithelial neoplasm Pulmonary blastoma 0.196 28 2.05e-44 5.13e-43 ✓ sig.
Hepatoblastoma Nasal cavity and paranasal sinus carcinoma 0.215 26 4.70e-44 1.17e-42 ✓ sig.
Benign thyroid gland neoplasm Follicular variant thyroid gland papillary carcinoma 0.328 20 5.82e-44 1.44e-42 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Ocular sebaceous carcinoma 0.221 25 7.40e-44 1.83e-42 ✓ sig.
Ovarian endometrioid adenocarcinoma Uterine corpus adenosarcoma 0.175 30 8.64e-44 2.14e-42 ✓ sig.
Carcinoma in situ Endometrium adenocarcinoma 0.184 29 1.02e-43 2.52e-42 ✓ sig.
Breast phyllodes tumor Non-functional pancreatic neuroendocrine tumor 0.193 28 1.27e-43 3.13e-42 ✓ sig.
Appendix goblet cell carcinoid Wolffian duct adenocarcinoma 0.242 23 2.28e-43 5.60e-42 ✓ sig.
Anaplastic oligodendroglioma Colorectal adenoma 0.112 52 3.57e-43 8.72e-42 ✓ sig.
Borderline ovarian mucinous tumor Nasal cavity and paranasal sinus carcinoma 0.223 23 2.00e-42 4.84e-41 ✓ sig.
Anaplastic large cell lymphoma Endometrial clear cell adenocarcinoma 0.164 29 5.13e-42 1.24e-40 ✓ sig.
Pseudomyxoma peritonei Small intestine adenocarcinoma 0.160 28 6.33e-42 1.53e-40 ✓ sig.
Pancreatic neuroendocrine tumor Spindle cell intraocular melanoma 0.129 29 1.21e-41 2.92e-40 ✓ sig.
Immunoblastic lymphadenopathy Metaplastic breast carcinoma 0.163 30 2.69e-41 6.44e-40 ✓ sig.
Differentiated thyroid carcinoma Lung sarcomatoid carcinoma 0.136 29 3.35e-41 8.00e-40 ✓ sig.
Lung sarcomatoid carcinoma Ovarian clear cell adenocarcinoma 0.135 29 3.96e-41 9.46e-40 ✓ sig.
Benign thyroid gland neoplasm Medullary carcinoma 0.154 24 5.22e-41 1.24e-39 ✓ sig.
Endometrial undifferentiated carcinoma Ocular sebaceous carcinoma 0.237 22 8.42e-41 2.00e-39 ✓ sig.
Seminoma Testicular seminoma 0.144 27 1.12e-40 2.65e-39 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Primary peritoneal carcinoma 0.145 30 1.76e-40 4.16e-39 ✓ sig.
Endometrium adenocarcinoma Major salivary gland carcinoma 0.183 24 1.93e-40 4.57e-39 ✓ sig.
Conjunctival intraepithelial neoplasm Wolffian adnexal tumor 0.189 24 2.14e-40 5.04e-39 ✓ sig.
Chondrosarcoma Medullary carcinoma 0.153 29 2.26e-40 5.34e-39 ✓ sig.
Endometrial mixed adenocarcinoma Ovarian endometrioid adenocarcinoma 0.174 27 3.10e-40 7.30e-39 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Invasive breast carcinoma 0.143 28 1.42e-39 3.33e-38 ✓ sig.
Breast phyllodes tumor Fibroadenoma 0.200 20 1.92e-39 4.47e-38 ✓ sig.
Hairy cell leukemia Lung benign neoplasm 0.152 27 2.14e-39 5.00e-38 ✓ sig.
Ovarian teratoma Sebaceous adenoma 0.295 18 2.26e-39 5.27e-38 ✓ sig.
Endometrium adenocarcinoma Non-functional pancreatic neuroendocrine tumor 0.167 27 2.55e-39 5.91e-38 ✓ sig.
Adrenal gland neuroblastoma Endometrium adenocarcinoma 0.172 25 7.23e-39 1.67e-37 ✓ sig.
Ovarian teratoma Sebaceous gland neoplasms 0.268 19 9.04e-39 2.08e-37 ✓ sig.
Endometrium adenocarcinoma Mucoepidermoid carcinoma of parotid gland 0.166 26 2.25e-38 5.15e-37 ✓ sig.
Mixed lobular and ductal breast carcinoma Parathyroid gland adenoma 0.121 28 2.31e-38 5.29e-37 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Vulvar intraepithelial neoplasia 0.137 25 3.31e-38 7.55e-37 ✓ sig.
Cervical adenosquamous carcinoma Uterine corpus adenosarcoma 0.163 22 6.41e-38 1.46e-36 ✓ sig.
Appendix adenocarcinoma Malignant conjunctival melanoma 0.183 21 8.04e-38 1.82e-36 ✓ sig.
Lung sclerosing hemangioma Peripheral t-cell lymphoma, not otherwise specified 0.139 26 1.07e-37 2.43e-36 ✓ sig.
Conjunctival intraepithelial neoplasm Hepatoblastoma 0.170 24 3.46e-37 7.80e-36 ✓ sig.
Appendix adenocarcinoma Major salivary gland carcinoma 0.176 22 8.12e-37 1.82e-35 ✓ sig.
Conjunctival intraepithelial neoplasm Malignant epithelioid mesothelioma 0.177 20 9.01e-37 2.02e-35 ✓ sig.
Endometrial mixed adenocarcinoma Major salivary gland carcinoma 0.175 22 1.04e-36 2.34e-35 ✓ sig.
Endometrium adenocarcinoma Hepatoblastoma 0.162 24 2.18e-36 4.85e-35 ✓ sig.
Sebaceous gland neoplasms Wolffian duct adenocarcinoma 0.254 18 2.35e-36 5.23e-35 ✓ sig.
Malignant syringoma Nasal cavity and paranasal sinus squamous cell carcinoma 0.188 21 2.61e-36 5.80e-35 ✓ sig.
Conjunctival intraepithelial neoplasm Luminal a breast carcinoma 0.159 25 2.97e-36 6.61e-35 ✓ sig.
Endometrioid stromal sarcoma Nasal cavity and paranasal sinus carcinoma 0.189 21 4.37e-36 9.67e-35 ✓ sig.
Clear cell adenocarcinoma Nasal cavity and paranasal sinus carcinoma 0.198 18 5.08e-36 1.12e-34 ✓ sig.
Ocular sebaceous carcinoma Sinonasal undifferentiated carcinoma 0.211 20 5.21e-36 1.15e-34 ✓ sig.
Conjunctival intraepithelial neoplasm Fibroadenoma 0.173 19 6.17e-36 1.36e-34 ✓ sig.
Aggressive nk-cell leukemia Nasal cavity and paranasal sinus carcinoma 0.173 23 7.34e-36 1.62e-34 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Wolffian adnexal tumor 0.188 21 7.40e-36 1.63e-34 ✓ sig.
Conjunctival intraepithelial neoplasm Schwannoma 0.161 24 9.94e-36 2.18e-34 ✓ sig.
Pleural epithelioid mesothelioma Spindle cell intraocular melanoma 0.113 26 1.37e-35 3.00e-34 ✓ sig.
Epidermal appendage tumor Ovarian teratoma 0.258 17 2.54e-35 5.54e-34 ✓ sig.
Medullary carcinoma Vulvar intraepithelial neoplasia 0.138 23 2.83e-35 6.16e-34 ✓ sig.
Endometrial undifferentiated carcinoma Major salivary gland carcinoma 0.216 19 3.08e-35 6.69e-34 ✓ sig.
Appendix adenocarcinoma Cervical adenosquamous carcinoma 0.171 20 4.11e-35 8.92e-34 ✓ sig.
Anaplastic large cell lymphoma Breast phyllodes tumor 0.163 23 8.16e-35 1.76e-33 ✓ sig.
Breast phyllodes tumor Schwannoma 0.163 23 8.16e-35 1.76e-33 ✓ sig.
Adrenal gland neuroblastoma Breast phyllodes tumor 0.167 22 1.78e-34 3.83e-33 ✓ sig.
Benign adrenal gland pheochromocytoma Combined hepatocellular carcinoma and cholangiocarcinoma 0.127 24 1.87e-34 4.03e-33 ✓ sig.
Ocular sebaceous carcinoma Ovarian carcinosarcoma 0.233 17 2.33e-34 4.99e-33 ✓ sig.
Carcinoid tumor Invasive breast carcinoma 0.129 25 3.30e-34 7.05e-33 ✓ sig.
Hairy cell leukemia Spitz nevus 0.135 24 3.72e-34 7.94e-33 ✓ sig.
Bladder cancer Epidermal appendage tumor 0.300 15 4.61e-34 9.83e-33 ✓ sig.
Differentiated thyroid carcinoma Parathyroid gland adenoma 0.115 25 9.91e-34 2.10e-32 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Sertoli-leydig cell tumor of ovary 0.184 18 2.33e-33 4.92e-32 ✓ sig.
Endometrium adenocarcinoma Thymic undifferentiated carcinoma 0.154 19 5.03e-33 1.06e-31 ✓ sig.
Bladder cancer Sebaceous gland neoplasms 0.263 15 1.39e-32 2.89e-31 ✓ sig.
Renal cell carcinoma Urinary bladder neoplasms 0.092 38 1.44e-32 2.99e-31 ✓ sig.
Colorectal adenoma Colorectal neoplasms 0.094 42 2.04e-32 4.22e-31 ✓ sig.
Immunoblastic lymphadenopathy Leiomyoma 0.148 21 2.16e-32 4.46e-31 ✓ sig.
Appendix goblet cell carcinoid Hepatoblastoma 0.171 20 2.16e-32 4.47e-31 ✓ sig.
Breast phyllodes tumor Mucoepidermoid carcinoma of parotid gland 0.152 22 2.33e-32 4.79e-31 ✓ sig.
Lobular carcinoma Urinary bladder neoplasms 0.090 38 2.99e-32 6.16e-31 ✓ sig.
Hepatoblastoma Wolffian duct adenocarcinoma 0.191 18 3.18e-32 6.55e-31 ✓ sig.
Benign thyroid gland neoplasm Thyroid gland oncocytic adenoma 0.171 18 4.85e-32 9.95e-31 ✓ sig.
Ganglioglioma Nasal cavity and paranasal sinus carcinoma 0.174 15 5.78e-32 1.18e-30 ✓ sig.
Endometrioid stromal sarcoma Malignant conjunctival melanoma 0.222 16 1.17e-31 2.37e-30 ✓ sig.
Skin angiosarcoma Spitz nevus 0.134 22 1.42e-31 2.87e-30 ✓ sig.
Endometrial undifferentiated carcinoma Ovarian carcinosarcoma 0.211 16 1.72e-31 3.47e-30 ✓ sig.
Ovarian carcinosarcoma Sinonasal undifferentiated carcinoma 0.211 16 1.72e-31 3.47e-30 ✓ sig.
Cortisol-producing adrenal cortex adenoma Small intestinal neuroendocrine tumor g1 0.131 22 1.73e-31 3.50e-30 ✓ sig.
Parathyroid gland adenoma Testicular seminoma 0.117 23 1.89e-31 3.81e-30 ✓ sig.
Borderline ovarian mucinous tumor Endometrial undifferentiated carcinoma 0.198 17 2.68e-31 5.39e-30 ✓ sig.
Lung adenocarcinoma in situ Nasal cavity and paranasal sinus carcinoma 0.173 17 2.97e-31 5.99e-30 ✓ sig.
Epidermal appendage tumor Ocular sebaceous carcinoma 0.211 16 3.11e-31 6.25e-30 ✓ sig.
Ovarian neoplasms Pancreatic neoplasms 0.101 31 3.62e-31 7.26e-30 ✓ sig.
Non-functional pancreatic neuroendocrine tumor Sebaceous gland neoplasms 0.168 18 4.63e-31 9.26e-30 ✓ sig.
Pseudomyxoma peritonei Pulmonary blastoma 0.167 19 6.80e-31 1.36e-29 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Testicular sex cord-stromal neoplasm 0.170 15 8.02e-31 1.60e-29 ✓ sig.
Clear cell adenocarcinoma Endometrial undifferentiated carcinoma 0.211 15 9.32e-31 1.85e-29 ✓ sig.
Primary peritoneal carcinoma Pulmonary blastoma 0.155 20 1.08e-30 2.15e-29 ✓ sig.
Bile duct papillary neoplasm Borderline ovarian mucinous tumor 0.255 13 2.95e-30 5.82e-29 ✓ sig.
Cervical adenosquamous carcinoma Endometrial undifferentiated carcinoma 0.198 16 3.23e-30 6.36e-29 ✓ sig.
Conjunctival intraepithelial neoplasm Hepatocellular adenoma 0.148 18 6.28e-30 1.23e-28 ✓ sig.
Endometrial undifferentiated carcinoma Spinal cord astrocytoma 0.193 16 9.09e-30 1.78e-28 ✓ sig.
Adrenal cortex carcinoma Pancreatic neoplasms 0.090 32 9.32e-30 1.82e-28 ✓ sig.
Giant cell glioblastoma Gliosarcoma 0.306 11 1.12e-29 2.18e-28 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Salivary gland neoplasms 0.146 20 1.20e-29 2.34e-28 ✓ sig.
Appendix goblet cell carcinoid Sertoli-leydig cell tumor of ovary 0.178 16 1.28e-29 2.48e-28 ✓ sig.
Extranodal nasal nk/t cell lymphoma Primary central chondrosarcoma 0.126 20 1.29e-29 2.50e-28 ✓ sig.
Mucoepidermoid carcinoma of parotid gland Sebaceous gland neoplasms 0.167 17 1.88e-29 3.63e-28 ✓ sig.
Colorectal neoplasms Ovarian neoplasms 0.087 41 3.24e-29 6.25e-28 ✓ sig.
Endometrial mixed adenocarcinoma Leiomyoma 0.142 19 3.26e-29 6.28e-28 ✓ sig.
Acinic cell breast carcinoma Nasal cavity and paranasal sinus carcinoma 0.163 16 3.65e-29 7.02e-28 ✓ sig.
Skin angiosarcoma Spindle cell intraocular melanoma 0.126 20 4.56e-29 8.78e-28 ✓ sig.
Malignant epithelioid mesothelioma Sinonasal undifferentiated carcinoma 0.195 15 5.48e-29 1.05e-27 ✓ sig.
Lung benign neoplasm Malignant syringoma 0.146 19 6.59e-29 1.26e-27 ✓ sig.
Melanocytic skin neoplasm Spindle cell melanoma 0.158 16 6.91e-29 1.33e-27 ✓ sig.
Peripheral t-cell lymphoma, not otherwise specified Urinary bladder neoplasms 0.104 28 7.13e-29 1.37e-27 ✓ sig.
Breast adenosis Nasal cavity and paranasal sinus carcinoma 0.155 13 8.29e-29 1.59e-27 ✓ sig.
Lobular carcinoma Lung neoplasms 0.084 44 1.32e-28 2.52e-27 ✓ sig.
Conjunctival intraepithelial neoplasm Lung sarcomatoid carcinoma 0.137 19 2.53e-28 4.79e-27 ✓ sig.
Endometrioid stromal sarcoma Ocular sebaceous carcinoma 0.176 16 3.63e-28 6.86e-27 ✓ sig.
Lung neoplasms Ovarian neoplasms 0.087 38 4.09e-28 7.71e-27 ✓ sig.
Lung sarcomatoid carcinoma Nasal cavity and paranasal sinus carcinoma 0.148 18 4.33e-28 8.14e-27 ✓ sig.
Endometrial undifferentiated carcinoma Malignant conjunctival melanoma 0.185 15 4.89e-28 9.20e-27 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Nasal cavity and paranasal sinus squamous cell carcinoma 0.152 17 6.62e-28 1.24e-26 ✓ sig.
Schwannoma Well-differentiated liposarcoma 0.156 17 7.27e-28 1.36e-26 ✓ sig.
Conjunctival intraepithelial neoplasm Salivary gland neoplasms 0.129 20 1.03e-27 1.91e-26 ✓ sig.
Leiomyoma Luminal b breast carcinoma 0.137 18 1.50e-27 2.77e-26 ✓ sig.
Myxofibrosarcoma Well-differentiated liposarcoma 0.197 14 1.54e-27 2.84e-26 ✓ sig.
Endometrial undifferentiated carcinoma Leiomyoma 0.167 16 2.08e-27 3.83e-26 ✓ sig.
Conjunctival intraepithelial neoplasm Invasive breast carcinoma 0.131 19 2.26e-27 4.16e-26 ✓ sig.
Endometrioid stromal sarcoma Ovarian teratoma 0.181 15 2.94e-27 5.40e-26 ✓ sig.
Choroid plexus papilloma Sebaceous gland neoplasms 0.220 13 3.57e-27 6.55e-26 ✓ sig.
Lung sclerosing hemangioma Pleural biphasic mesothelioma 0.136 18 3.75e-27 6.88e-26 ✓ sig.
Hepatocellular adenoma Immunoblastic lymphadenopathy 0.128 17 5.38e-27 9.80e-26 ✓ sig.
Luminal b breast carcinoma Lung sclerosing hemangioma 0.133 18 7.05e-27 1.28e-25 ✓ sig.
Endometrial undifferentiated carcinoma Skin appendage carcinoma 0.188 13 7.45e-27 1.35e-25 ✓ sig.
Leiomyoma Nasal cavity and paranasal sinus carcinoma 0.144 17 7.62e-27 1.38e-25 ✓ sig.
Hepatosplenic t-cell lymphoma Peripheral t-cell lymphoma, not otherwise specified 0.097 16 8.67e-27 1.57e-25 ✓ sig.
Acinic cell breast carcinoma Endometrial undifferentiated carcinoma 0.182 14 8.75e-27 1.58e-25 ✓ sig.
Anaplastic ependymoma Sebaceous gland neoplasms 0.213 13 1.08e-26 1.95e-25 ✓ sig.
Pancreatic neoplasms Pleural epithelioid mesothelioma 0.093 27 1.19e-26 2.14e-25 ✓ sig.
Malignant epithelioid mesothelioma Nasal cavity and paranasal sinus carcinoma 0.150 15 1.46e-26 2.63e-25 ✓ sig.
Ocular sebaceous carcinoma Testicular yolk sac tumor 0.188 13 2.02e-26 3.63e-25 ✓ sig.
Colorectal neoplasms Pancreatic neoplasms 0.080 30 2.29e-26 4.10e-25 ✓ sig.
Carcinosarcoma Wolffian duct adenocarcinoma 0.214 12 2.84e-26 5.02e-25 ✓ sig.
Aggressive nk-cell leukemia Primary central chondrosarcoma 0.148 16 3.85e-26 6.81e-25 ✓ sig.
Bladder cancer Ileal neuroendocrine tumor g1 0.275 11 3.93e-26 6.94e-25 ✓ sig.
Epidermal appendage tumor Ovarian yolk sac tumor 0.256 11 4.28e-26 7.55e-25 ✓ sig.
Anaplastic ependymoma Sebaceous adenoma 0.235 12 4.92e-26 8.65e-25 ✓ sig.
Benign adrenal gland pheochromocytoma Breast phyllodes tumor 0.134 17 5.43e-26 9.52e-25 ✓ sig.
Chondrosarcoma Primary central chondrosarcoma 0.145 16 6.18e-26 1.08e-24 ✓ sig.
Langerhans cell histiocytosis Sinonasal undifferentiated carcinoma 0.181 13 6.72e-26 1.17e-24 ✓ sig.
Epidermal appendage tumor Follicular variant thyroid gland papillary carcinoma 0.197 13 1.10e-25 1.91e-24 ✓ sig.
Pancreatic neuroendocrine tumor Testicular carcinoma 0.090 24 1.76e-25 3.06e-24 ✓ sig.
Kidney oncocytoma Uterine corpus adenosarcoma 0.115 16 2.89e-25 4.98e-24 ✓ sig.
Endometrial undifferentiated carcinoma Fibroadenoma 0.173 13 4.35e-25 7.46e-24 ✓ sig.
Fibroadenoma Sinonasal undifferentiated carcinoma 0.173 13 4.35e-25 7.46e-24 ✓ sig.
Lung sclerosing hemangioma Ocular sebaceous carcinoma 0.152 15 6.01e-25 1.03e-23 ✓ sig.
Epidermal appendage tumor Ovarian carcinosarcoma 0.211 12 7.26e-25 1.24e-23 ✓ sig.
Endometrial undifferentiated carcinoma Salivary gland neoplasms 0.136 16 1.13e-24 1.92e-23 ✓ sig.
Urinary bladder neoplasms Uterine corpus adenosarcoma 0.097 23 1.29e-24 2.19e-23 ✓ sig.
Immunoblastic lymphadenopathy Undifferentiated gallbladder carcinoma 0.117 15 1.77e-24 2.98e-23 ✓ sig.
Leiomyosarcoma Urinary bladder neoplasms 0.089 26 1.82e-24 3.07e-23 ✓ sig.
Acinic cell breast carcinoma Luminal a breast carcinoma 0.139 14 1.85e-24 3.10e-23 ✓ sig.
Clear cell adenocarcinoma Ovarian teratoma 0.190 12 2.22e-24 3.73e-23 ✓ sig.
Carcinoma in situ Thymoma 0.136 15 2.53e-24 4.23e-23 ✓ sig.
Seminoma Testicular teratoma 0.157 14 2.93e-24 4.89e-23 ✓ sig.
Epidermal appendage tumor Malignant conjunctival melanoma 0.197 12 3.77e-24 6.28e-23 ✓ sig.
Sertoli-leydig cell tumor of ovary Sinonasal undifferentiated carcinoma 0.163 13 5.87e-24 9.72e-23 ✓ sig.
Sinonasal undifferentiated carcinoma Vulvar intraepithelial neoplasia 0.152 14 6.09e-24 1.01e-22 ✓ sig.
Clear cell adenocarcinoma Well-differentiated liposarcoma 0.176 12 8.74e-24 1.44e-22 ✓ sig.
Leiomyosarcoma Testicular carcinoma 0.090 22 9.10e-24 1.50e-22 ✓ sig.
Choroid plexus papilloma Sebaceous adenoma 0.220 11 9.34e-24 1.54e-22 ✓ sig.
Bladder cancer Sebaceous adenoma 0.220 11 9.34e-24 1.54e-22 ✓ sig.
Borderline ovarian mucinous tumor Wolffian duct adenocarcinoma 0.167 13 1.05e-23 1.73e-22 ✓ sig.
Lung benign neoplasm Lung inflammatory myofibroblastic tumor 0.138 15 1.06e-23 1.74e-22 ✓ sig.
Granulosa cell tumor of ovary Lung sarcomatoid carcinoma 0.124 16 1.24e-23 2.03e-22 ✓ sig.
Lung sclerosing hemangioma Wolffian adnexal tumor 0.147 14 1.73e-23 2.83e-22 ✓ sig.
Ovarian carcinosarcoma Ovarian yolk sac tumor 0.238 10 1.84e-23 2.99e-22 ✓ sig.
Ovarian clear cell adenocarcinoma Pancreatic neoplasms 0.087 24 2.13e-23 3.45e-22 ✓ sig.
Anaplastic ependymoma Myxofibrosarcoma 0.208 11 3.47e-23 5.61e-22 ✓ sig.
Myxofibrosarcoma Sebaceous adenoma 0.208 11 3.47e-23 5.61e-22 ✓ sig.
Malignant ovarian mixed epithelial tumor Ocular sebaceous carcinoma 0.164 12 4.11e-23 6.62e-22 ✓ sig.
Choroid plexus papilloma Epidermal appendage tumor 0.204 11 4.58e-23 7.37e-22 ✓ sig.
Appendix adenocarcinoma Undifferentiated gallbladder carcinoma 0.119 14 4.65e-23 7.48e-22 ✓ sig.
Bladder cancer Bladder urachal adenocarcinoma 0.238 10 5.86e-23 9.37e-22 ✓ sig.
Endometrioid stromal sarcoma Lung benign neoplasm 0.140 14 6.05e-23 9.67e-22 ✓ sig.
Borderline ovarian mucinous tumor Malignant conjunctival melanoma 0.171 12 9.40e-23 1.50e-21 ✓ sig.
Chondrosarcoma Parathyroid gland adenoma 0.126 15 9.97e-23 1.59e-21 ✓ sig.
Oligoastrocytoma Sebaceous gland neoplasms 0.190 11 1.05e-22 1.67e-21 ✓ sig.
Salivary gland neoplasms Sinonasal undifferentiated carcinoma 0.126 15 1.08e-22 1.71e-21 ✓ sig.
Anaplastic ependymoma Epidermal appendage tumor 0.196 11 1.12e-22 1.77e-21 ✓ sig.
Kidney oncocytoma Luminal b breast carcinoma 0.119 14 1.34e-22 2.12e-21 ✓ sig.
Nasal cavity and paranasal sinus squamous cell carcinoma Seminoma 0.149 13 1.75e-22 2.77e-21 ✓ sig.
Sertoli-leydig cell tumor of ovary Wolffian adnexal tumor 0.162 12 2.09e-22 3.30e-21 ✓ sig.
Epidermal appendage tumor Lung adenocarcinoma in situ 0.190 11 2.55e-22 4.00e-21 ✓ sig.
Clear cell meningioma Ocular sebaceous carcinoma 0.156 12 3.02e-22 4.74e-21 ✓ sig.
Thymic undifferentiated carcinoma Wolffian adnexal tumor 0.160 12 3.17e-22 4.97e-21 ✓ sig.
Cervical adenosquamous carcinoma Ovarian teratoma 0.162 12 3.38e-22 5.30e-21 ✓ sig.
Cortisol-producing adrenal cortex adenoma Pseudomyxoma peritonei 0.132 14 3.87e-22 6.03e-21 ✓ sig.
Liver neoplasms Lung neoplasms 0.075 28 4.02e-22 6.26e-21 ✓ sig.
Breast phyllodes tumor Spindle cell intraocular melanoma 0.116 15 4.48e-22 6.97e-21 ✓ sig.
Bladder urachal adenocarcinoma Epidermal appendage tumor 0.208 10 5.34e-22 8.31e-21 ✓ sig.
Breast phyllodes tumor Melanocytic skin neoplasm 0.118 13 1.11e-21 1.71e-20 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Appendix adenocarcinoma 0.112 14 1.27e-21 1.96e-20 ✓ sig.
Cervical adenosquamous carcinoma Epidermal appendage tumor 0.175 11 1.57e-21 2.42e-20 ✓ sig.
Benign thyroid gland neoplasm Melanocytic neoplasm 0.175 11 1.61e-21 2.47e-20 ✓ sig.
Clear cell adenocarcinoma Myxofibrosarcoma 0.200 10 2.44e-21 3.73e-20 ✓ sig.
Bladder cancer Major salivary gland carcinoma 0.164 11 2.45e-21 3.74e-20 ✓ sig.
Appendix goblet cell carcinoid Testicular sertoli cell tumor 0.134 11 2.84e-21 4.33e-20 ✓ sig.
Epidermal appendage tumor Oligoastrocytoma 0.192 10 4.36e-21 6.62e-20 ✓ sig.
Colon adenoma Pseudomyxoma peritonei 0.140 12 5.13e-21 7.76e-20 ✓ sig.
Malignant ovarian mixed epithelial tumor Ovarian carcinosarcoma 0.192 10 5.43e-21 8.21e-20 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Malignant conjunctival melanoma 0.164 11 6.16e-21 9.30e-20 ✓ sig.
Bile duct papillary neoplasm Bladder cancer 0.225 9 6.49e-21 9.79e-20 ✓ sig.
Ocular sebaceous carcinoma Spinal cord astrocytoma 0.141 12 7.32e-21 1.10e-19 ✓ sig.
Kidney oncocytoma Pleural biphasic mesothelioma 0.112 13 9.81e-21 1.47e-19 ✓ sig.
Malignant epithelioid mesothelioma Ovarian teratoma 0.157 11 1.05e-20 1.57e-19 ✓ sig.
Borderline ovarian mucinous tumor Colon adenoma 0.157 11 1.43e-20 2.13e-19 ✓ sig.
Testicular teratoma Vulvar intraepithelial neoplasia 0.140 12 1.48e-20 2.21e-19 ✓ sig.
Bladder urachal adenocarcinoma Ovarian teratoma 0.167 10 1.49e-20 2.23e-19 ✓ sig.
Lung inflammatory myofibroblastic tumor Ocular sebaceous carcinoma 0.125 13 1.83e-20 2.73e-19 ✓ sig.
Seminoma Wolffian duct adenocarcinoma 0.138 12 1.87e-20 2.78e-19 ✓ sig.
Breast phyllodes tumor Solid pseudopapillary neoplasm of the pancreas 0.112 12 1.95e-20 2.90e-19 ✓ sig.
Ovarian teratoma Seminoma 0.136 12 2.50e-20 3.71e-19 ✓ sig.
Lung sclerosing hemangioma Thymoma 0.133 12 3.46e-20 5.11e-19 ✓ sig.
Poroma Sebaceous gland neoplasms 0.180 9 3.57e-20 5.27e-19 ✓ sig.
Clear cell meningioma Nasal cavity and paranasal sinus carcinoma 0.118 12 3.71e-20 5.48e-19 ✓ sig.
Urethra adenocarcinoma Wolffian duct adenocarcinoma 0.170 9 3.86e-20 5.69e-19 ✓ sig.
Bile duct papillary neoplasm Ovarian yolk sac tumor 0.267 8 4.01e-20 5.90e-19 ✓ sig.
Malignant conjunctival melanoma Ovarian yolk sac tumor 0.191 9 4.23e-20 6.22e-19 ✓ sig.
Testicular teratoma Wolffian adnexal tumor 0.133 12 4.45e-20 6.54e-19 ✓ sig.
Follicular variant thyroid gland papillary carcinoma Lung inflammatory myofibroblastic tumor 0.130 12 4.96e-20 7.27e-19 ✓ sig.
Borderline ovarian mucinous tumor Spinal cord astrocytoma 0.149 11 5.46e-20 7.98e-19 ✓ sig.
Adnexal spiradenoma/cylindroma of a sweat gland Breast phyllodes tumor 0.110 12 5.50e-20 8.03e-19 ✓ sig.
Nasal cavity and paranasal sinus carcinoma Undifferentiated gallbladder carcinoma 0.117 12 5.81e-20 8.48e-19 ✓ sig.
Bile duct papillary neoplasm Colon adenoma 0.191 9 6.07e-20 8.86e-19 ✓ sig.
Ileal neuroendocrine tumor g1 Ovarian carcinosarcoma 0.196 9 7.91e-20 1.15e-18 ✓ sig.
Mucoepidermoid carcinoma Mucoepidermoid carcinoma of parotid gland 0.119 12 8.94e-20 1.30e-18 ✓ sig.
Acinic cell breast carcinoma Malignant conjunctival melanoma 0.167 10 9.94e-20 1.44e-18 ✓ sig.
Epidermal appendage tumor Gliosarcoma 0.167 10 1.06e-19 1.54e-18 ✓ sig.
Langerhans cell histiocytosis Ovarian teratoma 0.156 10 1.22e-19 1.76e-18 ✓ sig.
Benign adrenal gland pheochromocytoma Seminoma 0.128 12 1.26e-19 1.82e-18 ✓ sig.
Carcinoma of pharynx Ovarian carcinosarcoma 0.191 9 1.34e-19 1.93e-18 ✓ sig.
Cortisol-producing adrenal cortex adenoma Lung adenocarcinoma in situ 0.136 11 1.35e-19 1.94e-18 ✓ sig.
Bile duct papillary neoplasm Gallbladder papillary neoplasm 0.304 7 1.42e-19 2.05e-18 ✓ sig.
Endometrial undifferentiated carcinoma Rectum malignant melanoma 0.141 10 1.49e-19 2.15e-18 ✓ sig.
Conjunctival intraepithelial neoplasm Testicular carcinoma 0.092 16 2.65e-19 3.78e-18 ✓ sig.
Benign thyroid gland neoplasm Epidermal appendage tumor 0.159 10 2.82e-19 4.01e-18 ✓ sig.
Bile duct papillary neoplasm Bladder urachal adenocarcinoma 0.235 8 2.92e-19 4.16e-18 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Mucoepidermoid carcinoma of parotid gland 0.114 12 3.93e-19 5.58e-18 ✓ sig.
Ocular sebaceous carcinoma Sezary syndrome 0.139 10 5.12e-19 7.26e-18 ✓ sig.
Appendix adenocarcinoma Pancreatic neoplasms 0.086 17 5.18e-19 7.34e-18 ✓ sig.
Ovarian yolk sac tumor Testicular yolk sac tumor 0.222 8 5.72e-19 8.09e-18 ✓ sig.
Borderline ovarian mucinous tumor Testicular teratoma 0.131 11 8.64e-19 1.21e-17 ✓ sig.
Sebaceous gland neoplasms Testicular sex cord-stromal neoplasm 0.164 9 9.08e-19 1.28e-17 ✓ sig.
Benign adrenal gland pheochromocytoma Sebaceous gland neoplasms 0.129 11 9.84e-19 1.38e-17 ✓ sig.
Hepatocellular adenoma Lung sclerosing hemangioma 0.126 11 1.28e-18 1.79e-17 ✓ sig.
Thymoma Well-differentiated liposarcoma 0.128 11 1.39e-18 1.94e-17 ✓ sig.
Anaplastic ependymoma Choroid plexus papilloma 0.173 9 1.40e-18 1.95e-17 ✓ sig.
Appendix goblet cell carcinoid Undifferentiated gallbladder carcinoma 0.117 11 1.49e-18 2.08e-17 ✓ sig.
Epidermal appendage tumor Langerhans cell histiocytosis 0.170 9 1.53e-18 2.12e-17 ✓ sig.
Skin appendage carcinoma Spinal cord astrocytoma 0.164 9 1.55e-18 2.15e-17 ✓ sig.
Endometrial undifferentiated carcinoma Hepatocellular adenoma 0.125 11 1.58e-18 2.20e-17 ✓ sig.
Hepatocellular adenoma Sinonasal undifferentiated carcinoma 0.125 11 1.58e-18 2.20e-17 ✓ sig.
Malignant ovarian mixed epithelial tumor Ovarian yolk sac tumor 0.205 8 1.64e-18 2.28e-17 ✓ sig.
Fibroadenoma Ovarian carcinosarcoma 0.167 9 2.66e-18 3.69e-17 ✓ sig.
Bladder cancer Lung adenocarcinoma in situ 0.167 9 2.66e-18 3.69e-17 ✓ sig.
Prostate neuroendocrine neoplasm Vulvar intraepithelial neoplasia 0.139 10 2.95e-18 4.07e-17 ✓ sig.
Desmoplastic/nodular medulloblastoma Testicular yolk sac tumor 0.233 7 3.73e-18 5.12e-17 ✓ sig.
Carcinoma of pharynx Wolffian duct adenocarcinoma 0.150 9 3.78e-18 5.19e-17 ✓ sig.
Carcinosarcoma Malignant pancreatic neoplasm 0.200 8 3.83e-18 5.25e-17 ✓ sig.
Urinary bladder neoplasms Uterine neoplasms 0.079 13 4.51e-18 6.17e-17 ✓ sig.
Fibroadenoma Thymic undifferentiated carcinoma 0.161 9 4.87e-18 6.64e-17 ✓ sig.
Epidermal appendage tumor Keratocystic odontogenic tumor 0.184 7 5.70e-18 7.76e-17 ✓ sig.
Mucoepidermoid carcinoma Vulvar intraepithelial neoplasia 0.135 10 5.70e-18 7.76e-17 ✓ sig.
Benign thyroid gland neoplasm Thyroid neoplasms 0.135 10 6.14e-18 8.36e-17 ✓ sig.
Gliosarcoma Sebaceous adenoma 0.158 9 7.26e-18 9.86e-17 ✓ sig.
Spitz nevus Thymoma 0.117 11 7.78e-18 1.05e-16 ✓ sig.
Testicular teratoma Thymic undifferentiated carcinoma 0.132 10 8.15e-18 1.10e-16 ✓ sig.
Immunoblastic lymphadenopathy Spleen angiosarcoma 0.085 10 8.16e-18 1.11e-16 ✓ sig.
Bile duct papillary neoplasm Lung adenocarcinoma in situ 0.178 8 1.26e-17 1.70e-16 ✓ sig.
Sebaceous gland neoplasms Thymoma 0.130 10 1.57e-17 2.10e-16 ✓ sig.
Breast adenosis Carcinosarcoma 0.233 7 1.76e-17 2.35e-16 ✓ sig.
Malignant ovarian mixed epithelial tumor Skin appendage carcinoma 0.182 8 1.83e-17 2.44e-16 ✓ sig.
Anaplastic oligoastrocytoma Ocular sebaceous carcinoma 0.123 10 2.00e-17 2.68e-16 ✓ sig.
Ovarian carcinosarcoma Testicular carcinoma 0.098 11 2.08e-17 2.77e-16 ✓ sig.
Cholangiocarcinoma Ovarian carcinosarcoma 0.148 9 2.48e-17 3.30e-16 ✓ sig.
Bile duct papillary neoplasm Cholangiocarcinoma 0.167 8 2.74e-17 3.64e-16 ✓ sig.
Follicular variant thyroid gland papillary carcinoma Thyroid neoplasms 0.125 10 3.34e-17 4.42e-16 ✓ sig.
Poroma Wolffian duct adenocarcinoma 0.145 8 4.03e-17 5.32e-16 ✓ sig.
Prostate neuroendocrine neoplasm Spitz nevus 0.118 10 4.22e-17 5.57e-16 ✓ sig.
Ileal neuroendocrine tumor g1 Sertoli-leydig cell tumor of ovary 0.167 8 4.42e-17 5.82e-16 ✓ sig.
Sebaceous adenoma Skin appendage carcinoma 0.170 8 4.63e-17 6.09e-16 ✓ sig.
Aggressive nk-cell leukemia Craniopharyngioma 0.106 10 6.14e-17 8.04e-16 ✓ sig.
Anaplastic ependymoma Thymoma type b3 0.167 8 6.93e-17 9.05e-16 ✓ sig.
Lung adenocarcinoma in situ Urethra clear cell adenocarcinoma 0.179 7 7.93e-17 1.03e-15 ✓ sig.
Clear cell adenocarcinoma Malignant ovarian mixed epithelial tumor 0.167 8 8.24e-17 1.07e-15 ✓ sig.
Epidermal appendage tumor Urethra clear cell adenocarcinoma 0.171 7 1.25e-16 1.61e-15 ✓ sig.
Appendix goblet cell carcinoid Melanocytic skin neoplasm 0.106 10 1.26e-16 1.63e-15 ✓ sig.
Breast adenosis Clear cell adenocarcinoma 0.194 7 1.34e-16 1.73e-15 ✓ sig.
Carcinosarcoma Ganglioglioma 0.206 7 1.37e-16 1.77e-15 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Endometrial undifferentiated carcinoma 0.112 10 1.86e-16 2.39e-15 ✓ sig.
Clear cell meningioma Wolffian duct adenocarcinoma 0.129 9 2.09e-16 2.68e-15 ✓ sig.
Endometrial mixed adenocarcinoma Hepatosplenic t-cell lymphoma 0.087 10 2.16e-16 2.77e-15 ✓ sig.
Melanocytic skin neoplasm Vulvar intraepithelial neoplasia 0.127 9 2.58e-16 3.30e-15 ✓ sig.
Anaplastic ependymoma Primary central chondrosarcoma 0.125 9 2.79e-16 3.57e-15 ✓ sig.
Undifferentiated gallbladder carcinoma Wolffian duct adenocarcinoma 0.127 9 2.86e-16 3.65e-15 ✓ sig.
Carcinoma of pharynx Spinal cord astrocytoma 0.145 8 2.92e-16 3.73e-15 ✓ sig.
Ileal neuroendocrine tumor g1 Testicular sex cord-stromal neoplasm 0.194 7 3.16e-16 4.02e-15 ✓ sig.
Testicular sertoli cell tumor Testicular sex cord-stromal neoplasm 0.194 7 3.16e-16 4.02e-15 ✓ sig.
Gliosarcoma Oligoastrocytoma 0.151 8 3.37e-16 4.28e-15 ✓ sig.
Follicular variant thyroid gland papillary carcinoma Melanocytic neoplasm 0.127 9 3.57e-16 4.53e-15 ✓ sig.
Clear cell adenocarcinoma Malignant epithelioid mesothelioma 0.151 8 3.66e-16 4.64e-15 ✓ sig.
Blue nevus Epidermal appendage tumor 0.163 7 5.39e-16 6.78e-15 ✓ sig.
Clear cell meningioma Wolffian adnexal tumor 0.120 9 5.72e-16 7.20e-15 ✓ sig.
Poroma Sebaceous adenoma 0.171 7 7.02e-16 8.80e-15 ✓ sig.
Thyroid gland oncocytic adenoma Thyroid neoplasms 0.091 11 7.95e-16 9.95e-15 ✓ sig.
Bladder urachal adenocarcinoma Gallbladder papillary neoplasm 0.222 6 8.15e-16 1.02e-14 ✓ sig.
Testicular sex cord-stromal neoplasm Testicular yolk sac tumor 0.175 7 1.30e-15 1.62e-14 ✓ sig.
Carcinosarcoma Testicular yolk sac tumor 0.175 7 1.30e-15 1.62e-14 ✓ sig.
Carcinosarcoma Desmoplastic/nodular medulloblastoma 0.222 6 1.30e-15 1.62e-14 ✓ sig.
Carcinosarcoma Langerhans cell histiocytosis 0.171 7 1.78e-15 2.20e-14 ✓ sig.
Choroid plexus papilloma Ganglioglioma 0.167 7 1.83e-15 2.26e-14 ✓ sig.
Carcinoma in situ Gastric adenosquamous carcinoma 0.094 9 2.02e-15 2.49e-14 ✓ sig.
Follicular dendritic cell sarcoma Major salivary gland carcinoma 0.127 7 2.94e-15 3.59e-14 ✓ sig.
Keratocystic odontogenic tumor Sebaceous adenoma 0.171 6 3.22e-15 3.92e-14 ✓ sig.
Adrenal gland pheochromocytoma Benign adrenal gland pheochromocytoma 0.118 8 3.33e-15 4.06e-14 ✓ sig.
Endometrial neoplasms Ovarian neoplasms 0.060 20 3.50e-15 4.26e-14 ✓ sig.
Melanocytic neoplasm Myxofibrosarcoma 0.131 8 3.74e-15 4.54e-14 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Bladder cancer 0.129 8 3.87e-15 4.70e-14 ✓ sig.
Cholangiocarcinoma Ocular sebaceous carcinoma 0.107 9 4.70e-15 5.69e-14 ✓ sig.
Giant cell tumor of bone Ovarian teratoma 0.127 7 5.02e-15 6.07e-14 ✓ sig.
Malignant germ cell tumor Ocular sebaceous carcinoma 0.106 9 6.19e-15 7.46e-14 ✓ sig.
Hepatosplenic t-cell lymphoma Langerhans cell histiocytosis 0.156 7 7.32e-15 8.78e-14 ✓ sig.
Bile duct papillary neoplasm Thymic undifferentiated carcinoma 0.146 7 7.85e-15 9.40e-14 ✓ sig.
Anaplastic oligoastrocytoma Malignant conjunctival melanoma 0.125 8 8.19e-15 9.80e-14 ✓ sig.
Borderline ovarian mucinous tumor Pancreatoblastoma 0.119 8 1.21e-14 1.44e-13 ✓ sig.
Clear cell adenocarcinoma Urethra clear cell adenocarcinoma 0.176 6 1.42e-14 1.68e-13 ✓ sig.
Adnexal spiradenoma/cylindroma of a sweat gland Wolffian duct adenocarcinoma 0.116 8 1.78e-14 2.09e-13 ✓ sig.
Carcinoma of pharynx Urethra adenocarcinoma 0.188 6 1.93e-14 2.28e-13 ✓ sig.
Hamartoma of lung Lung benign neoplasm 0.100 7 2.20e-14 2.59e-13 ✓ sig.
Clear cell adenocarcinoma Ovarian mixed germ cell neoplasm 0.171 6 2.63e-14 3.09e-13 ✓ sig.
Ganglioneuroblastoma Sezary syndrome 0.176 6 2.75e-14 3.22e-13 ✓ sig.
Ovarian carcinosarcoma Thymoma type b3 0.137 7 3.40e-14 3.96e-13 ✓ sig.
Sebaceous adenoma Urethra clear cell adenocarcinoma 0.158 6 3.52e-14 4.09e-13 ✓ sig.
Prostate neuroendocrine neoplasm Thymoma 0.113 8 3.72e-14 4.31e-13 ✓ sig.
Malignant conjunctival melanoma Rectum malignant melanoma 0.132 7 4.04e-14 4.67e-13 ✓ sig.
Bladder cancer Carcinoma of liver and intrahepatic biliary tract 0.162 6 4.22e-14 4.87e-13 ✓ sig.
Carcinoma of esophagus Gallbladder papillary neoplasm 0.263 5 4.36e-14 5.03e-13 ✓ sig.
Ovarian carcinosarcoma Sezary syndrome 0.135 7 4.72e-14 5.43e-13 ✓ sig.
Ileal neuroendocrine tumor g1 Ovarian yolk sac tumor 0.176 6 5.21e-14 5.99e-13 ✓ sig.
Colorectal neuroendocrine tumor g1 Ovarian carcinosarcoma 0.150 6 5.30e-14 6.09e-13 ✓ sig.
Borderline ovarian mucinous tumor Cholangiocarcinoma 0.110 8 6.17e-14 7.07e-13 ✓ sig.
Ameloblastoma Ovarian yolk sac tumor 0.227 5 6.45e-14 7.39e-13 ✓ sig.
Anaplastic ependymoma Carcinoma of esophagus 0.154 6 6.53e-14 7.47e-13 ✓ sig.
Ovarian mixed germ cell neoplasm Sebaceous adenoma 0.154 6 6.53e-14 7.47e-13 ✓ sig.
Mucoepidermoid carcinoma Thymoma type b3 0.130 7 6.63e-14 7.58e-13 ✓ sig.
Carcinoma of pharynx Ovarian yolk sac tumor 0.171 6 7.16e-14 8.16e-13 ✓ sig.
Bladder cancer Thymoma type ab 0.158 6 7.37e-14 8.39e-13 ✓ sig.
Clear cell meningioma Malignant ovarian mixed epithelial tumor 0.130 7 9.13e-14 1.03e-12 ✓ sig.
Ovarian yolk sac tumor Skin appendage carcinoma 0.167 6 9.67e-14 1.09e-12 ✓ sig.
Carcinoma of liver and intrahepatic biliary tract Lung adenocarcinoma in situ 0.146 6 9.82e-14 1.11e-12 ✓ sig.
Blue nevus Sebaceous adenoma 0.150 6 1.14e-13 1.29e-12 ✓ sig.
Lung adenocarcinoma in situ Solid pseudopapillary neoplasm of the pancreas 0.127 7 1.16e-13 1.31e-12 ✓ sig.
Bladder cancer Urethra adenocarcinoma 0.154 6 1.23e-13 1.38e-12 ✓ sig.
Aggressive nk-cell leukemia Gastric adenosquamous carcinoma 0.088 8 1.27e-13 1.43e-12 ✓ sig.
Gallbladder papillary neoplasm Rectum adenoma 0.227 5 1.48e-13 1.66e-12 ✓ sig.
Carcinosarcoma Testicular sertoli cell tumor 0.162 6 1.52e-13 1.71e-12 ✓ sig.
Ovarian yolk sac tumor Sezary syndrome 0.158 6 1.70e-13 1.90e-12 ✓ sig.
Anaplastic oligoastrocytoma Craniopharyngioma 0.123 7 1.92e-13 2.15e-12 ✓ sig.
Adrenal gland pheochromocytoma Ileal neuroendocrine tumor g1 0.158 6 2.09e-13 2.33e-12 ✓ sig.
Acinic cell breast carcinoma Breast adenosis 0.143 6 2.34e-13 2.61e-12 ✓ sig.
Benign neoplasm of pancreas Pseudomyxoma peritonei 0.094 8 2.64e-13 2.94e-12 ✓ sig.
Pancreatic insulinoma Sebaceous gland neoplasms 0.115 7 2.95e-13 3.28e-12 ✓ sig.
Epidermal appendage tumor Pancreatoblastoma 0.119 7 3.12e-13 3.46e-12 ✓ sig.
Liver neoplasms Ovarian neoplasms 0.054 19 4.39e-13 4.82e-12 ✓ sig.
Lung adenoma Ovarian carcinosarcoma 0.136 6 4.56e-13 5.01e-12 ✓ sig.
Mucoepidermoid carcinoma Sebaceous adenoma 0.115 7 4.98e-13 5.46e-12 ✓ sig.
Ovarian carcinosarcoma Prostate neuroendocrine neoplasm 0.115 7 5.21e-13 5.70e-12 ✓ sig.
Desmoplastic/nodular medulloblastoma Ovarian yolk sac tumor 0.200 5 5.31e-13 5.80e-12 ✓ sig.
Keratocystic odontogenic tumor Skin appendage carcinoma 0.179 5 5.69e-13 6.21e-12 ✓ sig.
Cerebellar pilocytic astrocytoma Pleomorphic xanthoastrocytoma 0.143 6 5.89e-13 6.42e-12 ✓ sig.
Acinic cell breast carcinoma Mucoepidermoid carcinoma 0.113 7 6.37e-13 6.92e-12 ✓ sig.
Malignant pancreatic neoplasm Testicular sertoli cell tumor 0.143 6 6.42e-13 6.98e-12 ✓ sig.
Choriocarcinoma of testis Choroid plexus papilloma 0.140 6 6.62e-13 7.19e-12 ✓ sig.
Epidermal appendage tumor Lung adenoma 0.130 6 6.68e-13 7.25e-12 ✓ sig.
Giant cell tumor of bone Sebaceous gland neoplasms 0.118 6 8.09e-13 8.76e-12 ✓ sig.
Bile duct papillary neoplasm Pancreatoblastoma 0.136 6 8.27e-13 8.94e-12 ✓ sig.
Endometrial neoplasms Hairy cell leukemia 0.058 15 9.99e-13 1.08e-11 ✓ sig.
Malignant conjunctival melanoma Prostate neuroendocrine neoplasm 0.108 7 1.25e-12 1.34e-11 ✓ sig.
Cholangiocarcinoma Epidermal appendage tumor 0.108 7 1.27e-12 1.36e-11 ✓ sig.
Endometrial neoplasms Uterine corpus adenosarcoma 0.059 14 1.30e-12 1.39e-11 ✓ sig.
Adrenal gland pheochromocytoma Malignant adrenal gland pheochromocytoma 0.172 5 1.63e-12 1.72e-11 ✓ sig.
Colon adenoma Ovarian yolk sac tumor 0.122 6 1.85e-12 1.95e-11 ✓ sig.
Melanocytic neoplasm Ovarian yolk sac tumor 0.122 6 1.85e-12 1.95e-11 ✓ sig.
Anaplastic oligoastrocytoma Ganglioglioma 0.125 6 1.87e-12 1.96e-11 ✓ sig.
Ganglioglioma Ovarian mixed germ cell neoplasm 0.179 5 2.00e-12 2.10e-11 ✓ sig.
Benign neoplasm of pancreas Testicular sertoli cell tumor 0.128 6 2.04e-12 2.14e-11 ✓ sig.
Benign neoplasm of pancreas Testicular sex cord-stromal neoplasm 0.128 6 2.04e-12 2.14e-11 ✓ sig.
Bladder urachal adenocarcinoma Urethra clear cell adenocarcinoma 0.167 5 2.79e-12 2.91e-11 ✓ sig.
Hepatosplenic t-cell lymphoma Solid pseudopapillary neoplasm of the pancreas 0.125 6 3.40e-12 3.54e-11 ✓ sig.
Breast adenosis Ovarian yolk sac tumor 0.172 5 3.44e-12 3.57e-11 ✓ sig.
Capillary hemangioma Carcinosarcoma 0.167 5 3.50e-12 3.64e-11 ✓ sig.
Desmoplastic/nodular medulloblastoma Malignant pancreatic neoplasm 0.152 5 4.07e-12 4.21e-11 ✓ sig.
Langerhans cell histiocytosis Solid pseudopapillary neoplasm of the pancreas 0.122 6 4.42e-12 4.57e-11 ✓ sig.
Cerebellar pilocytic astrocytoma Clear cell adenocarcinoma 0.122 6 4.46e-12 4.61e-11 ✓ sig.
Bladder urachal adenocarcinoma Carcinoma of liver and intrahepatic biliary tract 0.161 5 4.53e-12 4.68e-11 ✓ sig.
Ganglioglioma Urethra adenocarcinoma 0.167 5 4.67e-12 4.81e-11 ✓ sig.
Bile duct papillary neoplasm Urethra adenocarcinoma 0.167 5 4.67e-12 4.81e-11 ✓ sig.
Ovarian yolk sac tumor Rectum adenoma 0.167 5 5.00e-12 5.15e-11 ✓ sig.
Sebaceous adenoma Thymoma type b3 0.120 6 5.05e-12 5.20e-11 ✓ sig.
Liver neoplasms Urinary bladder neoplasms 0.055 15 5.36e-12 5.51e-11 ✓ sig.
Carcinosarcoma Kidney oncocytoma 0.115 6 5.38e-12 5.54e-11 ✓ sig.
Carcinosarcoma Ganglioneuroblastoma 0.161 5 5.45e-12 5.60e-11 ✓ sig.
Bone osteosarcoma Malignant pancreatic neoplasm 0.120 6 5.57e-12 5.72e-11 ✓ sig.
Endometrial neoplasms Endometrium adenocarcinoma 0.058 13 5.58e-12 5.73e-11 ✓ sig.
Ameloblastoma Gallbladder papillary neoplasm 0.267 4 6.13e-12 6.28e-11 ✓ sig.
Keratocystic odontogenic tumor Kidney oncocytoma 0.122 5 6.36e-12 6.50e-11 ✓ sig.
Bile duct papillary neoplasm Rectum adenoma 0.161 5 6.79e-12 6.88e-11 ✓ sig.
Benign neoplasm of pancreas Malignant pancreatic neoplasm 0.115 6 8.61e-12 8.69e-11 ✓ sig.
Anaplastic large cell lymphoma Hyperplastic polyp 0.078 7 8.88e-12 8.96e-11 ✓ sig.
Ameloblastoma Desmoplastic/nodular medulloblastoma 0.250 4 9.62e-12 9.71e-11 ✓ sig.
Colon adenoma Rectal neoplasm 0.111 6 9.98e-12 1.01e-10 ✓ sig.
Testicular sex cord-stromal neoplasm Yolk sac tumor 0.152 5 1.19e-11 1.19e-10 ✓ sig.
Colon adenoma Gallbladder papillary neoplasm 0.119 5 1.27e-11 1.28e-10 ✓ sig.
Bladder cancer Pancreatoblastoma 0.111 6 1.43e-11 1.43e-10 ✓ sig.
Bladder urachal adenocarcinoma Yolk sac tumor 0.147 5 1.53e-11 1.54e-10 ✓ sig.
Giant cell tumor of bone Malignant pancreatic neoplasm 0.139 5 1.76e-11 1.74e-10 ✓ sig.
Benign neoplasm of pancreas Bladder cancer 0.109 6 1.77e-11 1.76e-10 ✓ sig.
Carcinoma of pharynx Mediastinal yolk sac tumor 0.143 5 2.17e-11 2.14e-10 ✓ sig.
Hyperplasia Thyroid neoplasms 0.088 7 2.19e-11 2.16e-10 ✓ sig.
Bile duct papillary neoplasm Nasopharyngeal carcinoma 0.143 5 2.40e-11 2.37e-10 ✓ sig.
Ganglioglioma Pleomorphic xanthoastrocytoma 0.143 5 2.40e-11 2.37e-10 ✓ sig.
Malignant germ cell tumor Wolffian adnexal tumor 0.085 7 2.61e-11 2.56e-10 ✓ sig.
Carcinosarcoma Choriocarcinoma of testis 0.139 5 3.15e-11 3.08e-10 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Pancreatic insulinoma 0.100 6 3.42e-11 3.33e-10 ✓ sig.
Bladder urachal adenocarcinoma Choriocarcinoma of testis 0.135 5 4.07e-11 3.94e-10 ✓ sig.
Anaplastic ependymoma Thymoma type ab 0.122 5 4.53e-11 4.37e-10 ✓ sig.
Giant cell tumor of bone Keratocystic odontogenic tumor 0.200 4 5.25e-11 5.05e-10 ✓ sig.
Langerhans cell histiocytosis Mediastinal yolk sac tumor 0.128 5 5.41e-11 5.20e-10 ✓ sig.
Ileal neuroendocrine tumor g1 Rectum malignant melanoma 0.128 5 7.12e-11 6.73e-10 ✓ sig.
Ovarian carcinosarcoma Wilms tumor 0.097 6 7.46e-11 7.05e-10 ✓ sig.
Sertoli-leydig cell tumor of ovary Wilms tumor 0.095 6 9.04e-11 8.46e-10 ✓ sig.
Pituitary adenoma Wolffian adnexal tumor 0.087 6 9.10e-11 8.51e-10 ✓ sig.
Adrenocorticotropic hormone-producing pituitary gland adenoma Bone osteosarcoma 0.094 6 9.12e-11 8.53e-10 ✓ sig.
Gastric adenosquamous carcinoma Primary central chondrosarcoma 0.088 6 9.41e-11 8.80e-10 ✓ sig.
Myxofibrosarcoma Yolk sac tumor 0.114 5 1.17e-10 1.09e-9 ✓ sig.
Cerebellar pilocytic astrocytoma Ganglioglioma 0.119 5 1.24e-10 1.16e-9 ✓ sig.
Oligoastrocytoma Pleomorphic xanthoastrocytoma 0.119 5 1.35e-10 1.25e-9 ✓ sig.
Carcinosarcoma Pancreatic insulinoma 0.119 5 1.43e-10 1.32e-9 ✓ sig.
Bile duct papillary neoplasm Solid pseudopapillary neoplasm of the pancreas 0.116 5 1.51e-10 1.40e-9 ✓ sig.
Cystic neoplasm Ovarian yolk sac tumor 0.167 4 1.60e-10 1.48e-9 ✓ sig.
Keratocystic odontogenic tumor Ovarian yolk sac tumor 0.167 4 1.60e-10 1.48e-9 ✓ sig.
Carcinogenesis Epidermal appendage tumor 0.106 5 1.88e-10 1.72e-9 ✓ sig.
Carcinoma of esophagus Carcinoma of liver and intrahepatic biliary tract 0.174 4 2.12e-10 1.94e-9 ✓ sig.
Carcinoma of pharynx Cervical clear cell adenocarcinoma 0.148 4 2.13e-10 1.94e-9 ✓ sig.
Cystic neoplasm Nasopharyngeal carcinoma 0.154 4 2.54e-10 2.30e-9 ✓ sig.
Solid pseudopapillary neoplasm of the pancreas Undifferentiated pancreatic carcinoma with osteoclast-like giant cells 0.111 5 2.64e-10 2.39e-9 ✓ sig.
Blue nevus Capillary hemangioma 0.167 4 2.97e-10 2.68e-9 ✓ sig.
Follicular dendritic cell sarcoma Ganglioneuroblastoma 0.167 4 2.97e-10 2.68e-9 ✓ sig.
Epidermal appendage tumor Hyperplasia 0.086 6 3.08e-10 2.78e-9 ✓ sig.
Anaplastic oligoastrocytoma Spleen angiosarcoma 0.104 5 3.15e-10 2.84e-9 ✓ sig.
Craniopharyngioma Testicular sertoli cell tumor 0.109 5 3.19e-10 2.87e-9 ✓ sig.
Craniopharyngioma Testicular sex cord-stromal neoplasm 0.109 5 3.19e-10 2.87e-9 ✓ sig.
Bile duct papillary neoplasm Parotid gland acinic cell carcinoma 0.154 4 3.38e-10 3.03e-9 ✓ sig.
Lymphangiosarcoma Malignant germ cell tumor 0.100 5 3.56e-10 3.19e-9 ✓ sig.
Cerebellar pilocytic astrocytoma Rectal neoplasm 0.109 5 3.58e-10 3.21e-9 ✓ sig.
Adnexal spiradenoma/cylindroma of a sweat gland Carcinosarcoma 0.106 5 3.82e-10 3.41e-9 ✓ sig.
Malignant conjunctival melanoma Spleen angiosarcoma 0.098 5 4.92e-10 4.37e-9 ✓ sig.
Carcinoma of esophagus Rectum adenoma 0.154 4 5.40e-10 4.78e-9 ✓ sig.
Capillary hemangioma Poroma 0.154 4 5.40e-10 4.78e-9 ✓ sig.
Wilms tumor Wolffian duct adenocarcinoma 0.080 6 6.18e-10 5.44e-9 ✓ sig.
Colorectal neuroendocrine tumor g1 Ovarian yolk sac tumor 0.148 4 6.28e-10 5.53e-9 ✓ sig.
Carcinoma of pharynx Non-functioning adrenal cortex adenoma 0.138 4 6.37e-10 5.61e-9 ✓ sig.
Cystic neoplasm Sezary syndrome 0.129 4 6.61e-10 5.80e-9 ✓ sig.
Hamartoma of lung Parathyroid gland adenoma 0.076 5 7.10e-10 6.21e-9 ✓ sig.
Anaplastic oligoastrocytoma Undifferentiated pancreatic carcinoma with osteoclast-like giant cells 0.098 5 7.44e-10 6.50e-9 ✓ sig.
Choriocarcinoma of testis Urethra clear cell adenocarcinoma 0.143 4 7.96e-10 6.93e-9 ✓ sig.
Ganglioglioma Giant cell glioblastoma 0.143 4 7.96e-10 6.93e-9 ✓ sig.
Hamartoma of lung Lung inflammatory myofibroblastic tumor 0.072 5 9.25e-10 8.01e-9 ✓ sig.
Desmoplastic/nodular medulloblastoma Rectum malignant melanoma 0.133 4 1.00e-9 8.65e-9 ✓ sig.
Anaplastic ependymoma Pancreatic insulinoma 0.096 5 1.18e-9 1.02e-8 ✓ sig.
Bone osteosarcoma Cerebellar pilocytic astrocytoma 0.096 5 1.26e-9 1.08e-8 ✓ sig.
Ganglioneuroblastoma Ovarian yolk sac tumor 0.138 4 1.27e-9 1.09e-8 ✓ sig.
Adrenal gland pheochromocytoma Colorectal neuroendocrine tumor g1 0.129 4 1.50e-9 1.28e-8 ✓ sig.
Colorectal neuroendocrine tumor g1 Rectum malignant melanoma 0.129 4 1.50e-9 1.28e-8 ✓ sig.
Hyperplasia Ileal neuroendocrine tumor g1 0.088 5 1.75e-9 1.49e-8 ✓ sig.
Carcinoma of pharynx Follicular dendritic cell sarcoma 0.125 4 2.16e-9 1.82e-8 ✓ sig.
Breast adenosis Choriocarcinoma of testis 0.129 4 2.19e-9 1.84e-8 ✓ sig.
Giant cell tumor of bone Testicular sex cord-stromal neoplasm 0.125 4 2.48e-9 2.08e-8 ✓ sig.
Choriocarcinoma of testis Yolk sac tumor 0.125 4 2.92e-9 2.43e-8 ✓ sig.
Mediastinal yolk sac tumor Ovarian yolk sac tumor 0.125 4 3.01e-9 2.51e-8 ✓ sig.
Bladder urachal adenocarcinoma Thymoma type ab 0.121 4 3.03e-9 2.52e-8 ✓ sig.
Craniopharyngioma Desmoplastic/nodular medulloblastoma 0.108 4 3.24e-9 2.69e-8 ✓ sig.
Orbit embryonal rhabdomyosarcoma Rectum adenoma 0.121 4 3.64e-9 3.01e-8 ✓ sig.
Mixed germ cell tumor Skin appendage carcinoma 0.118 4 3.66e-9 3.03e-8 ✓ sig.
Adnexal spiradenoma/cylindroma of a sweat gland Desmoplastic/nodular medulloblastoma 0.105 4 3.74e-9 3.09e-8 ✓ sig.
Benign monoclonal gammopathy Mast cell leukemia 0.121 4 3.81e-9 3.15e-8 ✓ sig.
Gastric adenosquamous carcinoma Urethra adenocarcinoma 0.111 4 5.98e-9 4.88e-8 ✓ sig.
Nasopharyngeal carcinoma Ovarian yolk sac tumor 0.114 4 6.11e-9 4.99e-8 ✓ sig.
Ovarian yolk sac tumor Pleomorphic xanthoastrocytoma 0.114 4 6.11e-9 4.99e-8 ✓ sig.
Atypical teratoid rhabdoid tumor Choriocarcinoma of testis 0.114 4 6.20e-9 5.05e-8 ✓ sig.
Rectal neoplasm Rectum adenoma 0.111 4 6.65e-9 5.40e-8 ✓ sig.
Fibroadenoma Mediastinal malignant germ cell tumor 0.103 4 7.00e-9 5.69e-8 ✓ sig.
Ameloblastoma Borderline ovarian serous tumor 0.200 3 7.59e-9 6.13e-8 ✓ sig.
Hyperplasia Solid pseudopapillary neoplasm of the pancreas 0.078 5 8.34e-9 6.60e-8 ✓ sig.
Clear cell adenocarcinoma Papillary hidradenoma 0.103 4 9.87e-9 7.77e-8 ✓ sig.
Carcinogenesis Oligoastrocytoma 0.103 4 1.12e-8 8.80e-8 ✓ sig.
Nasopharyngeal carcinoma Undifferentiated pancreatic carcinoma with osteoclast-like giant cells 0.105 4 1.19e-8 9.36e-8 ✓ sig.
Malignant epithelioid mesothelioma Uterine neoplasms 0.076 5 1.33e-8 1.04e-7 ✓ sig.
Borderline ovarian serous tumor Gallbladder papillary neoplasm 0.176 3 1.62e-8 1.26e-7 ✓ sig.
Malignant adrenal gland pheochromocytoma Parotid gland carcinoma ex pleomorphic adenoma 0.167 3 2.23e-8 1.72e-7 ✓ sig.
Gallbladder papillary neoplasm Parotid gland acinic cell carcinoma 0.167 3 2.32e-8 1.78e-7 ✓ sig.
Adrenal gland pheochromocytoma Pituitary adenoma 0.095 4 2.66e-8 1.98e-7 ✓ sig.
Cerebellar pilocytic astrocytoma Mast cell leukemia 0.093 4 2.79e-8 2.08e-7 ✓ sig.
Colorectal neuroendocrine tumor g1 Cystic neoplasm 0.158 3 2.98e-8 2.22e-7 ✓ sig.
Colorectal neuroendocrine tumor g1 Mesonephric adenocarcinoma 0.158 3 2.98e-8 2.22e-7 ✓ sig.
Desmoplastic/nodular medulloblastoma Non-functioning adrenal cortex adenoma 0.158 3 3.19e-8 2.37e-7 ✓ sig.
Adrenal gland pheochromocytoma Pancreatic insulinoma 0.091 4 3.79e-8 2.81e-7 ✓ sig.
Sebaceous adenoma Spleen angiosarcoma 0.087 4 3.94e-8 2.92e-7 ✓ sig.
Colorectal neuroendocrine tumor g1 Gallbladder papillary neoplasm 0.150 3 4.25e-8 3.14e-7 ✓ sig.
Conjunctival intraepithelial neoplasm Syndromic intellectual disability 0.048 7 4.26e-8 3.15e-7 ✓ sig.
Lung adenoma Uterine neoplasms 0.080 4 4.91e-8 3.62e-7 ✓ sig.
Cervical clear cell adenocarcinoma Lung adenoma 0.136 3 5.05e-8 3.66e-7 ✓ sig.
Benign monoclonal gammopathy Colon adenoma 0.080 4 5.73e-8 4.13e-7 ✓ sig.
Ovarian yolk sac tumor Wilms tumor 0.082 4 5.79e-8 4.18e-7 ✓ sig.
Borderline ovarian serous tumor Lung adenoma 0.130 3 7.57e-8 5.38e-7 ✓ sig.
Capillary hemangioma Malignant adrenal gland pheochromocytoma 0.136 3 7.59e-8 5.40e-7 ✓ sig.
Giant cell glioblastoma Ovarian mixed germ cell neoplasm 0.130 3 1.01e-7 7.07e-7 ✓ sig.
Non-functioning adrenal cortex adenoma Rectum adenoma 0.125 3 1.08e-7 7.54e-7 ✓ sig.
Follicular dendritic cell sarcoma Mediastinal malignant germ cell tumor 0.125 3 1.31e-7 9.05e-7 ✓ sig.
Lung adenoma Primary cutaneous t-cell non-hodgkin lymphoma 0.120 3 1.49e-7 1.02e-6 ✓ sig.
Capillary hemangioma Mixed germ cell tumor 0.120 3 1.67e-7 1.13e-6 ✓ sig.
Mesonephric adenocarcinoma Testicular sertoli cell tumor 0.107 3 1.80e-7 1.20e-6 ✓ sig.
Mesonephric adenocarcinoma Testicular sex cord-stromal neoplasm 0.107 3 1.80e-7 1.20e-6 ✓ sig.
Cystic neoplasm Undifferentiated pancreatic carcinoma with osteoclast-like giant cells 0.107 3 1.80e-7 1.20e-6 ✓ sig.
Gallbladder papillary neoplasm Nasopharyngeal carcinoma 0.107 3 2.20e-7 1.47e-6 ✓ sig.
Carcinogenesis Carcinoma of liver and intrahepatic biliary tract 0.111 3 2.57e-7 1.70e-6 ✓ sig.
Mediastinal malignant germ cell tumor Mediastinal yolk sac tumor 0.107 3 3.12e-7 2.04e-6 ✓ sig.
Choriocarcinoma of testis Mediastinal malignant germ cell tumor 0.100 3 4.44e-7 2.85e-6 ✓ sig.
Gastric adenosquamous carcinoma Primary cutaneous t-cell non-hodgkin lymphoma 0.091 3 5.35e-7 3.38e-6 ✓ sig.
Primary cutaneous t-cell non-hodgkin lymphoma Thymoma type b3 0.091 3 5.35e-7 3.38e-6 ✓ sig.
Atypical teratoid rhabdoid tumor Thymoma type ab 0.097 3 5.65e-7 3.55e-6 ✓ sig.
Benign spiradenoma Papillary hidradenoma 0.097 3 5.95e-7 3.73e-6 ✓ sig.
Primary cutaneous t-cell non-hodgkin lymphoma Testicular yolk sac tumor 0.088 3 6.08e-7 3.81e-6 ✓ sig.
Giant cell glioblastoma Thymoma type b3 0.088 3 7.13e-7 4.43e-6 ✓ sig.
Syndromic intellectual disability Testicular teratoma 0.051 5 7.29e-7 4.53e-6 ✓ sig.
Hyperplastic polyp Mediastinal malignant germ cell tumor 0.088 3 8.10e-7 4.99e-6 ✓ sig.
Mast cell leukemia Poroma 0.091 3 8.68e-7 5.33e-6 ✓ sig.
Seminoma Syndromic intellectual disability 0.050 5 8.90e-7 5.46e-6 ✓ sig.
Benign spiradenoma Testicular sex cord-stromal neoplasm 0.081 3 1.73e-6 1.03e-5 ✓ sig.
Hyperplastic polyp Ovarian yolk sac tumor 0.077 3 2.30e-6 1.34e-5 ✓ sig.
Benign spiradenoma Thymoma type b3 0.075 3 2.63e-6 1.51e-5 ✓ sig.
Benign monoclonal gammopathy Cerebellar pilocytic astrocytoma 0.071 3 3.16e-6 1.81e-5 ✓ sig.
Choroid plexus papilloma Normal breast-like subtype of breast carcinoma 0.068 3 3.94e-6 2.22e-5 ✓ sig.
Malignant germ cell tumor Syndromic intellectual disability 0.046 4 7.42e-6 4.07e-5 ✓ sig.
Cervical clear cell adenocarcinoma Primary cutaneous t-cell non-hodgkin lymphoma 0.111 2 1.28e-5 6.85e-5 ✓ sig.
Gallbladder papillary neoplasm Mesonephric adenocarcinoma 0.111 2 1.35e-5 7.18e-5 ✓ sig.
Kidney neoplasms Nasopharyngeal carcinoma 0.053 3 1.63e-5 8.64e-5 ✓ sig.
Kidney neoplasms Pleomorphic xanthoastrocytoma 0.053 3 1.63e-5 8.64e-5 ✓ sig.
Cortical thymoma Parotid gland carcinoma ex pleomorphic adenoma 0.105 2 1.65e-5 8.70e-5 ✓ sig.
Benign monoclonal gammopathy Parotid gland carcinoma ex pleomorphic adenoma 0.080 2 4.06e-5 1.98e-4 ✓ sig.
Normal breast-like subtype of breast carcinoma Parotid gland carcinoma ex pleomorphic adenoma 0.080 2 4.06e-5 1.98e-4 ✓ sig.
Giant cell tumor of bone Hamartoma of lung 0.077 2 5.88e-5 1.98e-4 ✓ sig.
Normal breast-like subtype of breast carcinoma Urethra clear cell adenocarcinoma 0.071 2 7.44e-5 2.28e-4 ✓ sig.
Moyamoya angiopathy Sebaceous gland neoplasms 0.039 3 1.24e-4 3.27e-4 ✓ sig.
Cervical clear cell adenocarcinoma Polydactyly-macrocephaly syndrome 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Familial platelet disorder with associated myeloid malignancy Parotid gland carcinoma ex pleomorphic adenoma 0.100 1 5.81e-4 1.00e-3 ✓ sig.
Joint contractures, osteochondromas, and b-cell lymphoma Primary cutaneous t-cell non-hodgkin lymphoma 0.083 1 7.10e-4 1.17e-3 ✓ sig.
Primary cutaneous t-cell non-hodgkin lymphoma Sifrim-hitz-weiss syndrome 0.083 1 7.10e-4 1.17e-3 ✓ sig.
Cortical thymoma Thrombocytopenia 6 0.083 1 7.10e-4 1.17e-3 ✓ sig.
Bile duct papillary neoplasm Moyamoya angiopathy 0.037 2 8.76e-4 1.39e-3 ✓ sig.
Familial platelet disorder with associated myeloid malignancy Thymoma type ab 0.067 1 9.04e-4 1.41e-3 ✓ sig.
Blue nevus Intellectual developmental disorder, autosomal dominant 48 0.067 1 9.04e-4 1.41e-3 ✓ sig.
Mixed germ cell tumor Shukla-vernon syndrome 0.067 1 9.04e-4 1.41e-3 ✓ sig.
Moyamoya angiopathy Pleomorphic xanthoastrocytoma 0.036 2 9.72e-4 1.50e-3 ✓ sig.
Familial platelet disorder with associated myeloid malignancy Yolk sac tumor 0.059 1 1.03e-3 1.57e-3 ✓ sig.
Benign spiradenoma Shukla-vernon syndrome 0.053 1 1.16e-3 1.73e-3 ✓ sig.
Skeletal defects, genital hypoplasia, and impaired intellectual development Spleen angiosarcoma 0.053 1 1.16e-3 1.73e-3 ✓ sig.
Pleomorphic xanthoastrocytoma Shukla-vernon syndrome 0.048 1 1.29e-3 1.89e-3 ✓ sig.
Orbit embryonal rhabdomyosarcoma Thrombocytopenia 6 0.048 1 1.29e-3 1.89e-3 ✓ sig.
Ileal neuroendocrine tumor g1 Thrombocytopenia 6 0.045 1 1.36e-3 1.97e-3 ✓ sig.
Testicular sex cord-stromal neoplasm Thrombocytopenia 6 0.045 1 1.36e-3 1.97e-3 ✓ sig.
Intellectual developmental disorder, autosomal dominant 48 Rectum malignant melanoma 0.043 1 1.42e-3 2.04e-3 ✓ sig.
Adrenal gland pheochromocytoma Polydactyly-macrocephaly syndrome 0.043 1 1.42e-3 2.04e-3 ✓ sig.
Carcinoma of pharynx Polydactyly-macrocephaly syndrome 0.043 1 1.42e-3 2.04e-3 ✓ sig.
Bladder urachal adenocarcinoma Sifrim-hitz-weiss syndrome 0.043 1 1.42e-3 2.04e-3 ✓ sig.
Rectal neoplasm Shukla-vernon syndrome 0.042 1 1.49e-3 2.12e-3 ✓ sig.
Giant cell glioblastoma Mountain sickness 0.071 1 1.55e-3 2.19e-3 ✓ sig.
Gastric adenosquamous carcinoma Joint contractures, osteochondromas, and b-cell lymphoma 0.040 1 1.55e-3 2.19e-3 ✓ sig.
Gastric adenosquamous carcinoma Kinsship syndrome 0.040 1 1.55e-3 2.19e-3 ✓ sig.
Gastric adenosquamous carcinoma Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.040 1 1.55e-3 2.19e-3 ✓ sig.
Sifrim-hitz-weiss syndrome Thymoma type b3 0.040 1 1.55e-3 2.19e-3 ✓ sig.
Cervicitis Sezary syndrome 0.038 1 1.61e-3 2.26e-3 ✓ sig.
Cerebellar pilocytic astrocytoma Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.036 1 1.74e-3 2.42e-3 ✓ sig.
Pancreatoblastoma Pulmonary alveolar microlithiasis 0.032 1 1.94e-3 2.65e-3 ✓ sig.
Adnexal spiradenoma/cylindroma of a sweat gland Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0.032 1 1.94e-3 2.65e-3 ✓ sig.
Clear cell meningioma Immunodeficiency 92 0.030 1 2.07e-3 2.79e-3 ✓ sig.
Fibromatosis, gingival, 5 Wilms tumor 0.029 1 2.20e-3 2.92e-3 ✓ sig.
Colon adenoma Kinsship syndrome 0.027 1 2.32e-3 3.05e-3 ✓ sig.
Cholangiocarcinoma Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0.027 1 2.32e-3 3.05e-3 ✓ sig.
Melanocytic neoplasm Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.027 1 2.32e-3 3.05e-3 ✓ sig.
Moyamoya angiopathy Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language 0.027 1 2.32e-3 3.05e-3 ✓ sig.
Gabriele-de vries syndrome Uterine neoplasms 0.026 1 2.39e-3 3.12e-3 ✓ sig.
Intellectual developmental disorder, autosomal dominant 48 Malignant germ cell tumor 0.026 1 2.39e-3 3.12e-3 ✓ sig.
Borderline personality disorder Kidney neoplasms 0.025 1 2.52e-3 3.27e-3 ✓ sig.
Cervicitis Kidney neoplasms 0.025 1 2.52e-3 3.27e-3 ✓ sig.
Immunodeficiency 109 with lymphoproliferation Kidney neoplasms 0.025 1 2.52e-3 3.27e-3 ✓ sig.
Hepatocellular adenoma Immunodeficiency 92 0.024 1 2.58e-3 3.34e-3 ✓ sig.
Immunodeficiency 92 Thymoma 0.022 1 2.84e-3 3.63e-3 ✓ sig.
Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities Thymoma 0.022 1 2.84e-3 3.63e-3 ✓ sig.
Diets-jongmans syndrome Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Intellectual developmental disorder dysmorphic ocular Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Mental retardation, autosomal recessive 67 Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Neurodevelopmental, jaw, eye, and digital syndrome Syndromic intellectual disability 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Syndromic intellectual disability Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0.019 1 3.42e-3 4.29e-3 ✓ sig.
Lung inflammatory myofibroblastic tumor Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.016 1 3.87e-3 4.77e-3 ✓ sig.
Pulmonary alveolar microlithiasis Spitz nevus 0.016 1 3.87e-3 4.77e-3 ✓ sig.
Pseudomyxoma peritonei Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0.016 1 3.94e-3 4.83e-3 ✓ sig.
Kinsship syndrome Lung benign neoplasm 0.016 1 4.07e-3 4.99e-3 ✓ sig.
Autoinflammatory disease, systemic, with vasculitis Invasive breast carcinoma 0.015 1 4.13e-3 5.06e-3 ✓ sig.
Gliosarcoma Mountain sickness 0.028 1 4.39e-3 5.34e-3 ✓ sig.
Aggressive nk-cell leukemia Pulmonary alveolar microlithiasis 0.013 1 4.78e-3 5.75e-3 ✓ sig.
Joint contractures, osteochondromas, and b-cell lymphoma Luminal a breast carcinoma 0.012 1 5.29e-3 6.29e-3 ✓ sig.
Luminal a breast carcinoma Pulmonary alveolar microlithiasis 0.012 1 5.29e-3 6.29e-3 ✓ sig.
Granulosa cell tumor of ovary Oculomotor-abducens synkinesis 0.011 1 5.55e-3 6.59e-3 ✓ sig.
Diaphragm disease Leiomyoma 0.018 1 6.83e-3 7.94e-3 ✓ sig.
Oculomotor-abducens synkinesis Ovarian mucinous adenocarcinoma 0.007 1 8.78e-3 9.93e-3 ✓ sig.
Immunodeficiency 96 Urinary bladder neoplasms 0.007 1 9.04e-3 1.02e-2 ✓ sig.
Autosomal recessive osteopetrosis 8 Liver neoplasms 0.007 1 9.62e-3 1.08e-2 ✓ sig.
Liver neoplasms Pulmonary agenesis 0.007 1 9.62e-3 1.08e-2 ✓ sig.
Liver neoplasms Retinitis pigmentosa, hearing loss, premature aging, short stature, facial dysmorphism syndrome 0.007 1 9.62e-3 1.08e-2 ✓ sig.
Diaphragm disease Salivary gland neoplasms 0.013 1 9.66e-3 1.08e-2 ✓ sig.
Combined hepatocellular carcinoma and cholangiocarcinoma Oculomotor-abducens synkinesis 0.006 1 1.03e-2 1.14e-2 ✓ sig.
Autoinflammatory disease, systemic, with vasculitis Neoplasm of mature b-cells 0.005 1 1.21e-2 1.34e-2 ✓ sig.
Abdominal obesity-metabolic syndrome 3 Ovarian neoplasms 0.004 1 1.44e-2 1.58e-2 ✓ sig.
Extraoral halitosis due to methanethiol oxidase deficiency Ovarian neoplasms 0.004 1 1.44e-2 1.58e-2 ✓ sig.
Extraoral halitosis due to methanethiol oxidase deficiency Lung neoplasms 0.004 1 1.61e-2 1.75e-2 ✓ sig.
Hyperchlorhidrosis, isolated Lung neoplasms 0.004 1 1.61e-2 1.75e-2 ✓ sig.
Lung neoplasms Pulmonary agenesis 0.004 1 1.61e-2 1.75e-2 ✓ sig.
Colobomatous macrophthalmia microcornea syndrome Neuroblastoma 0.004 1 1.71e-2 1.85e-2 ✓ sig.
Hyperchlorhidrosis, isolated Neuroblastoma 0.004 1 1.71e-2 1.85e-2 ✓ sig.
Colorectal neoplasms Extraoral halitosis due to methanethiol oxidase deficiency 0.003 1 1.85e-2 2.00e-2 ✓ sig.
Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly Renal cell carcinoma 0.003 1 2.01e-2 2.16e-2 ✓ sig.